2012 Olympics Anti-Doping Laboratory
The 2012 London Olympics is the first Olympic event to have an anti-doping laboratory sponsored by a pharmaceutical company after GlaxoSmithKline (GSK) proposed to sponsor the anti-doping programme.
3B Blackbio Biotech India Manufacturing Plant, India
The Indo-Spanish joint venture (JV) company 3B Blackbio Biotech India opened a new biotech plant in Bhopal, Madhya Pradesh state in April 2011.
Abbott Laboratories Biotech Facility, Puerto Rico
Puerto Rico has a growing reputation as a biotech and pharmaceutical hub ('Bio Island') and plays host to manufacturing facilities from the world's largest pharmaceutical companies.
ABC Laboratories, Pharmaceutical Facility – Discovery Ridge, USA
Analytical Bio-Chemistry (ABC) Laboratories Inc is a major privately owned contract research organisation in the US. The
Abcam Global Headquarters, Cambridge
In June 2017, UK-based life sciences company Abcam began building its new global headquarters building at the Cambridge Biomedical Campus (CBC) in Cambridge, UK.
AbCellera Biologics’ GMP Manufacturing Facility, Vancouver, Canada
Canadian biotechnology firm AbCellera Biologics is to build a good manufacturing practice (GMP) antibody manufacturing facility in Vancouver.
Abzena’s Biotherapeutics Manufacturing Facility Relocation, San Diego
Abzena is expanding its biotherapeutics manufacturing operations by relocating to a new leased facility in Lusk Boulevard, San Diego, US.
Abzena’s cGMP Biologics Manufacturing Facility, Sanford, North Carolina
Abzena is expanding its cGMP biologics manufacturing capacity by opening a 120,000ft² facility in Sanford, North Carolina.
Accucaps Industries, Manufacturing Capacity – Canada
Accucaps Industries is a contract manufacturer for the soft gelatine encapsulation of pharmaceutical and nutritional compounds based in North America. The company has been in operation since 1989.
Achillion Pharmaceuticals Biotech Facility
Achillion Pharmaceuticals was founded in February 2000 as one of the largest biotech start-ups in the USA.
Acino Rivastigmine Patches Manufacturing Plant, Miesbach
Acino opened a new pharmaceutical manufacturing plant in Miesbach, Germany, in August 2012. The plant, owned and managed by Acino Holding, produces commercial quantities of transdermal rivastigmine patches.
Aenova’s Biologics and Vaccines Manufacturing Facility Expansion, Latina, Italy
Aenova’s existing site in Latina has been equipped with a sterile fill and finish area for vials and prefilled syringes (PFSs).
Aeroton Adcock Ingram Critical Care (AICC) Factory, Gauteng
The Adcock Ingram Critical Care (AICC) factory is an integrated pharmaceutical manufacturing and medical-grade plastics production facility in Aeroton, South Africa.
Aesica Containment Facility
Aesica, a supplier of active pharmaceutical ingredients, opened a new High Capacity Manufacturing facility at its Queenborough site in September 2013.
Affymetrix Inc, Manufacturing Facility – Singapore
Affymetrix Inc was one of the pioneering companies in genetic microarray technology in the 1980s. It now manufactures pr
AGC Biologics’ Manufacturing Facility Expansion, Heidelberg, Germany
AGC Biologics is expanding its manufacturing facility in Heidelberg to scale up the production of plasmid DNA and messenger RNA.
Agendia Genomics Laboratory California
Agendia, a genomics cancer diagnostics company, opened a new clinical genomics laboratory on 5 August 2010. Located in
Agilent Technologies’ Pharmaceutical Facility, Frederick, Colorado
US-based analytical technology company Agilent Technologies has opened a multi-structure pharmaceutical manufacturing plant in Frederick, Weld County, Colorado. The facility's construction began in October 2016 and it was opened in June 2019.
AGORA Cancer Centre, Lausanne
The AGORA cancer centre is being built at the Lausanne University Hospital site next to Lake Geneva, Switzerland.
Akron Biotechnology’s Ancillary Materials Manufacturing Facility, Sarasota, Florida
Akron Biotechnology is developing a manufacturing facility in the city of Sarasota in Florida, US to produce cell and gene therapy materials and technologies.
Albert Sherman Center, UMMS
The University of Massachusetts Medical School (UMMS), the US, expanded its research and curriculum teaching capabilities with the opening of the new Albert Sherman Center in January 2013.
Alcami’s Analytical Testing Facility, St Louis, Missouri
US-based pharmaceutical company Alcami has relocated its existing analytical testing facility in Missouri to the Cortex Innovation Centre in Central West End, St Louis.
Alcon Pharmaceutical Facility, Singapore
A Swiss pharmaceutical company founded in 1945, Alcon manufactures and markets pharmaceuticals, surgical equipment and devices, contact lenses and other vision care products.
Aldevron GMP Plasmid Manufacturing Facility, Fargo, North Dakota, US
In March 2018, US-based biotechnology company Aldevron began construction of a good manufacturing practice (GMP) compliant plasmid manufacturing facility in Fargo, North Dakota.
Alewife Research Centre (ARC), Cambridge, Massachusetts
The Davis Companies (TDC), a US-based real estate firm, has developed the Alewife Research Centre (ARC), a research centre in West Cambridge, Massachusetts.
Alexion Pharmaceuticals Global Headquarters, New Haven
In June 2013, US-based pharmaceutical company Alexion Pharmaceuticals began building its new global headquarters in New Haven, Connecticut.
Allergan Manufacturing Facility Expansion, Waco, Texas
Ireland-based pharmaceutical company Allergan, which produces eye-care and dermatological products, began an expansion of its manufacturing facility in Texas Central Park in Waco, Texas, in April 2016.
Almac Commercial Manufacturing Facility
Global pharmaceutical services provider Almac Group completed the expansion of its commercial pharmaceutical manufactu
Alnylam’s Manufacturing Facility, Norton, Massachusetts
Alnylam Pharmaceuticals is constructing a new manufacturing facility in Norton, Massachusetts, US. The company broke ground on the $200m facility on 28 April 2016.
Altana Pharma Solid Dosage Finishing Plant
The Altana Pharma solid dosage plant in Carrigtwohill, County Cork, Republic of Ireland, is owned by Gilead Sciences. Gi
Althea Technologies Biologics Manufacturing Facility, San Diego
Althea Technologies has launched a commercial-scale GMP manufacturing facility in Sorrento Valley area, a major biotechnology hub in San Diego, California.
Altman Clinical and Translational Research Institute (CTRI), San Diego
In January 2013, the University of California, San Diego (UCSD) began building the Altman Clinical and Translational Research Institute (CTRI) building at La Jolla in San Diego, California.
Alvotech Biosimilar Manufacturing Facility, Reykjavik
Iceland-based biopharmaceutical company Alvotech officially opened a biosimilar facility in Reykjavik on 8 June 2016. The facility will be dedicated to the production of biosimilars of monoclonal antibodies (mAbs).
Amgen Helix Project
The Helix Project is a major research and development facility constructed by Amgen (ex Immunex) in Seattle. It is calle
Amgen Pharmaceutical Manufacturing Facility
West Greenwich, Rhode Island, US, is the site of a new pharmaceutical manufacturing facility dedicated to the production
Amgen Process Development Facility
Bothell is the site of a process development facility owned by the pharmaceuticals firm Immunex (now owned by Amgen).
Amgen’s Drug Substance Manufacturing Plant, Wake County, North Carolina
Amgen will build its second manufacturing facility in the US to support rising demand for its drugs, with a $550m investment.
Amgen’s Manufacturing Facility Expansion, Dun Laoghaire, Ireland
US-based biotechnology company Amgen opened its newly expanded manufacturing facility in Dun Laoghaire, Ireland, in August 2015.
Amgen’s New Bio-manufacturing Plant, Rhode Island, US
US-based biopharmaceutical company Amgen is developing a bio-manufacturing facility at its campus in West Greenwich, Rhode Island, US.
Amicus Therapeutics’ Global Research and Gene Therapy Centre, Philadelphia
Amicus Therapeutics built a global research and gene therapy centre of excellence in Philadelphia, Pennsylvania, US.
AMRI cGMP Manufacturing Sterile Fill and Finish Facility
Albany Molecular Research (AMRI) operates a cGMP manufacturing sterile fill and finish facility in Burlington, Massach
Amway Nutrilite Vitamins Manufacturing Facility, Ada, Michigan
US-based direct-selling company Amway started building a Nutrilite® production facility near Ada, Michigan, in May 2013.
Amway NUTRILITE® Botanical Concentrate Manufacturing Facility
Amway, a direct-selling company based in the US, is constructing a new manufacturing facility at Quincy in Washington, US, for its NUTRILITE® Botanical Concentrates.
Amylin Pharmaceutical – West Chester, Ohio, USA
Amylin Pharmaceuticals is a biopharmaceutical firm located in San Diego, California, with over 1,000 employees in the US
Aphena Pharma’s Solid Dose Division Expansion, Cookeville, Tennessee
Aphena Pharma is expanding its solid dose division in Cookeville, Tennessee, by adding bottle packaging capacity.
Aptar Pharma’s Manufacturing Facility, Navi Mumbai
Aptar Pharma, which is part of the AptarGroup, inaugurated its new manufacturing site in Mumbai, the commercial capital of India.
Argonne National Laboratory’s Advanced Protein Crystallisation Facility
Argonne National Laboratory is building a new advanced protein crystallisation facility (APCF) in Illinois, US. The $34.5m facility will help scientists across the world.
Argos Therapeutics Biomanufacturing Facility, Durham, North Carolina
In October 2014, US-based biopharmaceutical company Argos Therapeutics began building a biomanufacturing facility at Research Triangle Park in Durham, North Carolina.
Arranta Bio’s Boxborough Facility, Massachusetts
Arranta Bio, a US-based microbiome contract development and manufacturing organisation (CDMO), is building a manufacturing facility in Boxborough, Massachusetts.
Arranta’s New Commercial-Ready Manufacturing Facility, Watertown, Massachusetts
Arranta Bio is constructing a new multi-product, commercial-ready manufacturing facility in Watertown, Massachusetts, US.
Arrowhead Pharmaceuticals’ New Manufacturing and Laboratory Facilities, Verona, Wisconsin, USA
Arrowhead plans to invest up to $250m in the construction of a new manufacturing plant and associated lab facilities in Verona.
Artiva Biotherapeutics’ NK Cell Therapy Research and GMP Manufacturing Facility, San Diego, USA
Artiva’s San Diego manufacturing facility will bolster its NK cell therapy pipeline development and supply chain for clinical studies.
Ash Stevens Riverview Facility
Michigan-based contract pharmaceutical manufacturing company Ash Stevens operates two facilities for API process development and production.
Aspen Pharma’s High-Containment Manufacturing Facility, Port Elizabeth
In May 2018, pharmaceutical manufacturing firm Aspen Pharma opened a high-containment facility in Port Elizabeth, South Africa.
Astellas Institute for Regenerative Medicine Relocation
Japanese pharmaceutical company Astellas Pharma has announced plans to relocate its wholly-owned US subsidiary, Astellas Institute for Regenerative Medicine (AIRM), in December 2017.
Astellas Pharma’s New Manufacturing Facility, Toyama
Astellas Pharma unveiled its plans to construct an active pharmaceutical ingredient (API) manufacturing facility in Toyama, Japan, in January 2020.
AstraZeneca API Manufacturing Facility, Dublin, Ireland
AstraZeneca’s API plant will manufacture small molecules for drugs in late-stage development and early marketing.
AstraZeneca API Manufacturing Plant, Bristol, UK
AstraZeneca opened a manufacturing plant at their Bristol site in May 2003. The plant required a total investment of $145m (£90m) over a period of four years.
AstraZeneca Biologics Manufacturing Facility, Södertälje
Anglo-Swedish pharmaceutical group AstraZeneca is developing a state-of-the-art facility for manufacturing biological medicines in Södertälje, Sweden.
AstraZeneca Biopharmaceutical Manufacturing
DSM Biologics completed the construction of the first phase of a substantial expansion to its large-scale biopharmaceuti
AstraZeneca Large Scale Laboratory (LSL) Facility, Macclesfield, UK
AstraZeneca's large-scale laboratory (LSL) project was instigated as a brownfield development in Macclesfield, UK.
AstraZeneca Pharmaceutical Manufacturing Plant, Wuxi, Shanghai, China
In early 2001, AstraZeneca inaugurated a pharmaceutical plant in the Wuxi region of northeastern China.
AstraZeneca Pharmaceuticals Complex, Södartälje, Sweden
The project is a pharmaceuticals plant located at Snackviken, in Södartälje, Sweden. It is owned by AstraZeneca, which was formed by a merger of Swedish Astra and British Zeneca.
AstraZeneca R&D Centre and Corporate Headquarters, Cambridge, UK
AstraZeneca built its global R&D centre and corporate headquarters at the Cambridge Biomedical Campus with a $1.3bn investment.
AstraZeneca R&D Facility, Alderley Park, Cheshire
AstraZeneca's Alderley Park site is the company's largest R&D facility. Located in the middle of Cheshire in the nor
AstraZeneca Solid Forms Production Plant, Cairo, Egypt
AstraZeneca's pharmaceutical production facility in Sixth of October City (Madinat Sittah Uktubar), near Cairo, produces
AstraZeneca Symbicort Production Facility, Dunkirk
AstraZeneca France's Dunkirk plant has been sold to Minafin, a subsidiary of the Minakem Group. The acquisition was comp
AstraZeneca’s Bulk Pharmaceutical Purification Plant, Guayama, Puerto Rico
In July 1997, AstraZeneca announced plans to invest £15m in its Guayama facility in Puerto Rico.
AstraZeneca’s Manufacturing Facility, North Ryde, Sydney
AstraZeneca’s manufacturing facility in North Ryde, Sydney, Australia is involved in the production and export of medicines, and has been operational for more than 60 years.
AstraZeneca’s New Manufacturing Facility, Taizhou
AstraZeneca started production at its a new manufacturing facility at Taizhou in Jiangsu province of China in October 2014. The facility manufactures intravenous and oral solid medicines for the Chinese market.
Athenex Biotech Plant, Dunkirk, New York
US-based pharmaceutical company Athenex, in partnership with the State University of New York Polytechnic Institute (SUNY Polytechnic Institute), is building a high pharmacy oncology manufacturing facility in Dunkirk, New York, to manufacture sterile high-potency oncology drugs.
ATMI Bloomington Manufacturing Facility
ATMI LifeSciences completed a $45.5m (€34.8m) expansion to its manufacturing facility in Bloomington, Minnes
Audentes’ Gene Therapy Manufacturing Facility, Sanford, North Carolina
Audentes Therapeutics, a genetic medicines company, is planning to build a gene therapy manufacturing facility in Sanford, North Carolina, US.
Autolus Therapeutics’ CAR-T Cell Manufacturing Facility, Stevenage, UK
Biotechnology company Autolus Therapeutics is building the UK’s first CAR-T cell manufacturing facility in Stevenage.
Avantor’s Life Sciences Research Centre, New Jersey
Avantor Performance Materials has opened a life sciences research centre in Bridgewater, New Jersey.
Early in 2003, Aventis Pharma Germany completed their third insulin plant in Frankfurt, Germany. The new plant produces
Aventis’ Enoxaparin Sodium Manufacturing Plant, Jurong Island, Singapore
Aventis' Jurong Island facility for the manufacture of enoxaparin sodium was opened in July 1999.
AveXis Gene Therapy Manufacturing Facility, North Carolina, US
AveXis is investing an additional $60m in its new gene therapy manufacturing facility in Durham County, North Carolina, US.
B Braun Medical Infusion Technology Facility
B Braun opened its infusion technology facility at its global headquarters in Melsungan, Germany, on 02 June 2010.
Bactolac Pharmaceutical Facility, New York
Bactolac Pharmaceutical's new manufacturing facility in New York, US, is located alongside its existing facility in Haup
BASi Discovery Center, Indiana
Bioanalytics Systems, also known as BASi, is a US-based pharmaceutical research company. It offers contract laboratory services to pharmaceutical companies.
Bavarian Nordic Smallpox Vaccine Facility
The Danish biotech company Bavarian Nordic has set up a new smallpox vaccine production facility in Kvistgård, Nort
Baxalta Biologics Facility, Georgia, US
US-based biopharmaceutical company Baxalta, a spin-off of Baxter International, began building a biologics facility in Georgia, US, in August 2012.
Baxter BioPharma Solutions Parenteral
Baxter BioPharma Solutions is a contract manufacturer of pre-filled syringes, vials and cartridges for the packaging of vaccines and drugs to treat chronic conditions such as rheumatoid arthritis and multiple sclerosis.
Baxter Cytotoxic Contract Manufacturing Facility
Baxter Biopharma Solutions is expanding its cytotoxic manufacturing facility in Halle in Westfalen, Germany. It is one
Baxter Healthcare Cartago Facility
Baxter International is a diversified healthcare company with a presence in several countries. The company is segmented
Baxter R&D Facility
Baxter's new research and development facility was launched in June 2010 in Belgium.
Bayer Corporation Biotechnology Plant, Berkeley, California, US
In August 2000, the Bayer Corporation was granted permission by the city of Berkeley to develop an additional 14 acres s
Bayer Healthcare Cell Biology Centre, Wuppertal
Bayer Healthcare broke ground for a new biopharmaceutical manufacturing facility in Wuppertal, Germany on 13 December
Bayer Healthcare Pharmaceuticals Plant, Snohomish County, Washington State
Berlex Laboratories LLC based in Bothell, Washington was the US subsidiary of the German pharmaceutical company Schering
Bayer Healthcare Pharmaceuticals R&D Centre
Bayer Healthcare Pharmaceuticals opened an R&D facility in San Francisco, California, US, in January 2011.
Bayer’s Cell Culture Technology Centre, California, US
Bayer is building a cell culture technology centre in California for the development of biological therapies.
Bayer’s New Contraceptive Production Facility, Turku, Finland
German multinational pharmaceutical and life sciences company Bayer is building a contraceptive production facility in Turku, Finland.
Bayer’s Solida-1 Pharmaceutical Production Facility, Leverkusen, Germany
Bayer is developing the Solida-1 pharmaceutical facility in Leverkusen, Germany, to produce solid pharmaceutical products.
BD Biosciences Production Facility
BD Biosciences, a division of the New Jersey based medical technology company BD (Becton, Dickinson and Company), laun
BeiGene Biologics Manufacturing Facility, Guangzhou, China
BeiGene Biologics, a joint venture (JV) of BeiGene Hong Kong and Guangzhou GET Technology Development, is developing a biologics manufacturing facility in Guangzhou in China's Guangdong province.
BeiGene’s New Manufacturing and Clinical R&D Centre, Hopewell, USA
BeiGene's new manufacturing and clinical R&D centre in Hopewell, New Jersey, will focus on developing novel cancer medications.
Beike Biotechnology Stem Cell Storage and Processing Facility, Jiangsu
Beike Biotechnology, in association with Jiangsu Government's China Medical City, has opened a stem cell storage and
Berkshire Sterile Manufacturing Facility Expansion, Lee, Massachusetts
Berkshire Sterile Manufacturing (BSM) is expanding its manufacturing facility in Lee, Massachusetts.
Bharat Biotech, Vaccine Production Plant, Perak
With the ascendancy of the Indian pharmaceutical and biotech industries has come expansion and, in some cases, foreign i
Bidachem Active Pharmaceutical Ingredients Plant, Bergamo
Bidachem SPA is one of the major manufacturers of fine chemicals and active pharmaceutical ingredients (APIs) in Italy.
Bigelow Centre for Blue Biotechnology
The Bigelow Centre for Blue Biotechnology, (BCBB) is a new research centre built in East Boothbay, Maine, US. It conducts frontline research on applying the ocean's microbial ecosystems to biopharmaceuticals.
BioBAT Bioscience Center
BioBAT, a research and biomanufacturing project, is a non-profit partnership between New York City Economic Development
BioCentriq Cell and Gene Therapy Manufacturing Centre, Newark, US
BioCentriq is a clinical manufacturing facility for cell and gene therapies under development at the New Jersey Institute of Technology (NJIT) university in Newark, New Jersey, US, the first cell and gene therapy development and manufacturing centre established on a university campus in the country.
BioCina’s Biologics Manufacturing Facility, Adelaide, Australia
BioCina has opened Australia’s first bacterial cell-based facility that meets regulatory criteria for medicinal products.
Biodesign C Research Building, Arizona State University, Tempe, Arizona
In September 2018, Arizona State University (ASU) officially opened its Biodesign C research building at the Biodesign Institute complex in Tempe, Arizona, US.
Biogen Idec Pharmaceutical Production Facility
In March 2003 Biogen Idec began construction of its first production facility to be located outside of the USA. The plan
Biogen’s Biologics Manufacturing Facility, Solothurn, Switzerland
US-based biotechnology company Biogen is developing a biologics manufacturing facility in Luterbach near Solothurn, Switzerland.
Biolab Research and Development Centre, Mississauga
Brazilian pharmaceutical firm Biolab Farmacêutica has opened a research and development (R&D) centre in Mississauga in the Greater Toronto Area (GTA) of Ontario, Canada.
Biolex Therapeutics Facility Expansion, Pittsboro, North Carolina
Biolex Therapeutics is a biotech company involved in the development and commercialisation of complex proteins and monoc
BioMalta Life Sciences Park, San Gwann, Malta
BioMalta is a state-of-the-art life sciences park in San Gwann, Malta, sponsored by the Maltese Government.
BioMarin cGMP Manufacturing Facility
BioMarin Pharmaceutical is a biotechnology firm headquartered in Novato, California. The company's operations in Novat
Biomedical Engineering and Advanced Manufacturing Centre, Ontario, Canada
The Biomedical Engineering and Advanced Manufacturing (BEAM) centre is located in McMaster Innovation Park in Hamilton, Ontario.
Biomedicum Research Laboratory, Karolinska Institute
Biomedicum is one of the largest experimental biomedical research laboratories in Europe.
Bioniche Life Sciences’ Vaccine Manufacturing Facility, Belleville, Ontario
Canada-based biopharmaceutical company Bioniche Life Sciences launched a new livestock manufacturing facility on 29 Ap
Bionova’s GMP Biologics Manufacturing Facility, Fremont, California
Bionova’s Fremont manufacturing facility produces clinical supply for clients using mammalian cell culture trains.
BioNTech mRNA Vaccine Manufacturing Facility, Rwanda
BioNTech is building its first manufacturing facility in Kigali, Rwanda, to support the production of mRNA vaccines in Africa.
BioNTech’s COVID-19 Vaccine Manufacturing Facility, Marburg
BioNTech’s manufacturing site in Marburg, Germany, will be used for the production of its Covid-19 vaccine candidate, BNT162.
Biopol Allergy Immunotherapy Manufacturing Facility, Idaho
Biopol Laboratory, a subsidiary of the ALK-Abelló Group, completed the construction of a new manufacturing and rese
Biopolis Biomedical Research Hub, Buona Vista
Biopolis is a custom-built biomedical research and development (R&D) hub at One-North, Buona Vista, Queenstown, Singapore. Covering 183ha of land, the hub is aimed to benefit a range of disciplines.
Biosciences Partnership Building, Phoenix, Arizona
In October 2014, the University of Arizona (UA) College of Medicine in Phoenix, Arizona, broke ground on the Biosciences Partnership Building research facility.
Biosite HQ and Manufacturing Campus, Mera Misa, California
The Biosite headquarters and manufacturing unit in Mera Misa, San diego, California was completed in August 2006. Biosi
BioSolutions New Manufacturing Facility
Emergent BioSolutions launched a new biotechnology manufacturing facility on 16 July 2010. Formerly known as the MdBio
Biovectra mRNA Vaccine and Biomanufacturing Centre, Charlottetown, Canada
Scheduled for completion in 2023, Biovectra’s new facility will provide space to support mRNA and pDNA expansions.
BioVectra’s Biologics Manufacturing Facility Expansion, Canada
In March 2019, BioVectra announced plans to expand its biologics manufacturing facility in Windsor, Nova Scotia, Canada.
Bipha Human Serum Albumin Plant, Hokkaido, Japan
The Chitose project is a human serum albumin (HSA) production plant that uses a genetic biologic recombination process.
Blu Pharmaceuticals Facility
Kentucky-based generic drug sales and distribution company Blu Pharmaceuticals opened a new facility in the town of Do
In March 2002 Boehringer Ingelheim opened their new manufacturing facility in Pudong, Zhangjiang High Tech Park in Shang
Boehringer Ingelheim Active Ingredients Plant
Boehringer Ingelheim officially opened the new active ingredients plant in Ingelheim in early 2003. The plant will be ab
Boehringer Ingelheim Biologicals Development Centre (BDC), Biberach, Germany
Boehringer Ingelheim is developing a biologicals development centre (BDC) within its plant site in Biberach, Germany.
Boehringer Ingelheim Biopharmaceutical Production
Boehringer Ingelheim is one of the leading biotech companies in Europe and has consolidated this position in the last th
Boehringer Ingelheim Biopharmaceuticals Project, Shanghai
German pharmaceutical company Boehringer Ingelheim is developing a biologics manufacturing facility at the Zhang Jiang Hi-tech Park in Shanghai.
Boehringer Ingelheim Biotechnology Process Plant, Biberach, Germany
In 2000, biotechnology company Boehringer Ingelheim awarded Stuttgart company Life Science Meissner & Wurst an engineering contract for the expansion of its Biberach plant.
Boehringer Ingelheim microParts Atomisation Factory
Boehringer Ingelheim microParts, a subsidiary of Boehringer Ingelheim Group, invested $94m in a new atomisation factory in Dortmund as part of its expansion strategy.
Boehringer Ingelheim Pharmaceutical R&D Building, Biberach, Germany
Boehringer Ingelheim is a Germany-based company with interests in pharmaceuticals, biopharmaceuticals, chemicals and ani
Boehringer Ingelheim Research Institute of Molecular Pathology (IMP)
The construction of a research facility for the Research Institute of Molecular Pathology (IMP) at the Vienna Biocentre in the third district of Vienna, Austria, fully sponsored by Boehringer Ingelheim, began in March 2015.
Boehringer Ingelheim’s New Tablet Production Facility, Ingelheim
Germany-based pharmaceutical company, Boehringer Ingelheim, is building a tablet production facility in Ingelheim, Germany, with an estimated investment of more than €85m ($97.2m).
Boehringer Ingelheim’s US Headquarters
Germany-based privately held pharmaceutical company Boehringer Ingelheim invested more than $350m in 2011 to boost its operations in the US.
Boehringer Ingelheim’s Biopharmaceutical Production Facility, Vienna, Austria
Boehringer Ingelheim’s large-scale cell culture production facility opened in October 2021.
Boehringer Ingelheim’s Integrated Asian Veterinary R&D Centre, Shanghai
Germany-based pharmaceutical company Boehringer Ingelheim’s veterinary research and development (R&D) centre is located within its research and development (R&D) site in Shanghai, China.
Boehringer Ingelheim’s Manufacturing Facility Expansion, Fremont, California
German pharmaceutical company Boehringer Ingelheim has broken ground on a $217m expansion of its facility in Fremont, California.
Brecon Pharmaceutical Manufacturing Expansion, Hay-On-Wye, Hereford
Brecon Pharmaceuticals Ltd, a subsidiary of AmerisourceBergen, is based in the Wye Valley Business Park near Hay-on-Wye
Brigham Translational Research and Clinical Facility, Boston
The construction of the Brigham translational research and clinical facility, also known as the Brigham Building for the Future (BBF), was initiated by the Brigham and Women’s Hospital (BWH) in June 2013.
Bristol Myers Squibb Biologics Manufacturing Facility, County Dublin
In November 2014, Bristol Myers Squibb (BMS), a global pharmaceutical company based in New York, announced plans to build a state-of-the-art biologics manufacturing facility in County Dublin, Ireland.
Bristol Myers Squibb East Syracuse Pharmaceutical Manufacturing Facility
The Bristol Myers Squibb East Syracuse campus is more than 60 years old. Launched in 1943, the pharmaceutical manufacturing facility made nearly 70% of the penicillin produced in the world until the mid-2000s.
Bristol Myers Squibb’s New CAR-T Cell Therapy Facility, Leiden, Netherlands
US-based pharmaceutical company Bristol Myers Squibb (BMS) is to build a new Chimeric Antigen Receptor T-cell (CAR-T) therapy manufacturing facility at the Leiden Bio Science Park in Leiden, Netherlands.
In 2006, Bristol-Myers Squibb (BMS) announced a major investment of $220m (€176m) for the expansion of its biol
Bristol-Myers Squibb – Clinical Supplies Manufacturing
Bristol-Myers Squibb (BMS) has been undergoing much the same rationalisation process as many large pharmaceutical compan
Bristol-Myers Squibb Manufacturing Plant, Devens, Massachusetts
In June 2006, US-based pharmaceutical company Bristol-Myers Squibb pledged to build a large-scale multi-product biopharmaceutical manufacturing plant in Devens, Massachusetts.
Bristol-Myers Squibb’s Bulk Manufacturing Facility in Cruiserath, Ireland
In November 2000, Bristol-Myers Squibb began the construction of a new bulk manufacturing facility in the Republic of Ireland.
Bristol-Myers Squibb’s New Cell Therapy Manufacturing Facility, Devens, Massachusetts, US
Bristol-Myers Squibb (BMS), a global pharmaceutical company based in the US, is constructing a new cell therapy manufacturing facility in Devens, Massachusetts, US.
Buck Institute Regenerative Medicine Research Center, California
The New Regenerative Medicine Research Center in California was opened in April 2012. It focuses on how the regeneration of human cells can be used for treating fatal diseases.
Building Cure, Seattle Children’s Research Institute, Seattle
Seattle Children's Research Institute (SCRI) is building a paediatric research building, Building Cure, at Stewart Street in Seattle.
Bushu Pharmaceuticals’ Manufacturing Facility Expansion, Misato, Japan
Bushu Pharmaceuticals unveiled a new expansion programme for its pharmaceutical manufacturing facility in Misato, Japan, in August 2020.
C Wayne McIlwraith Translational Medicine Institute, Colorado State University
In June 2017, Colorado State University (CSU) started building the C Wayne McIlwraith Translational Medicine Institute (TMI).
Cambrex Corporation API Facility Expansion, Charles City, Iowa
In July 2016, US-based innovative life sciences company Cambrex Corporation completed a major expansion of its active pharmaceutical ingredient (API) facility in Charles City, Iowa.
Cambrex Profarmaco, Paullo
Cambrex Profarmaco, Cambrex's Milan facility, is a cGMP manufacturing facility located 25km southeast of Milan, Italy. T
Cambrex’s Biopharmaceutical Facility Expansion, Durham, North Carolina
Cambrex expanded its biopharmaceutical analysis capabilities at its Durham facility in North Carolina, US.
Cambridge Major Laboratories Active Pharmaceutical
Cambridge Major Laboratories constructed a large active pharmaceutical ingredients (API) production facility in Germanto
Cambridge Major Laboratories New Active Pharmaceutical Ingredient (API) Facility
Cambridge Major Laboratories (CML) opened a new active pharmaceutical ingredient (API) facility in July 2009. Located
Cancer and Cardiovascular Research Building, University of Minnesota
The Cancer and Cardiovascular Research Building at 23rd Avenue, south-east of Minneapolis, Minnesota, US, was officially opened in June 2013.
CanSino Ebola Vaccine Manufacturing Facility, Tianjin, China
In October 2015, Tianjin CanSino Biotechnology (CanSino) began building its first fully integrated Ebola vaccine manufacturing facility in the Tianjin Economic-Technological Development Area (TEDA) west zone in China.
Capella Biomedical Research Laboratory, Cambridge Biomedical Campus
In February 2016, the construction of a laboratory building known as Project Capella began at the Cambridge Biomedical Campus in Cambridge, UK.
Capsugel Spray-Dried Dispersion Facility, Bend City, Oregon
In June 2015, US-based pharmaceutical company Capsugel finished building a pharmaceutical spray-dried dispersion (SDD) commercial manufacturing facility at its existing research and development (R&D) facility in Bend City, Oregon.
CARsgen Therapeutics’ CAR T-Cell Therapy Manufacturing Facility, North Carolina
CARsgen Therapeutics opened its first US cGMP manufacturing facility in North Carolina for producing CAR-T-cell products.
Cascade Chemistry’s Manufacturing Facility Expansion, Eugene
Cascade Chemistry, an American pharmaceutical contract development and manufacturing organisation (CDMO), is constructing new facilities to expand the current good manufacturing practices (cGMP) pharmaceutical manufacturing capacity of its Eugene site in the US.
Catalent Biomanufacturing Center of Excellence, Madison, Wisconsin
Catalent Pharma Solutions opened a state-of-the-art bio-manufacturing centre of excellence in Madison, Wisconsin, US, in April 2013.
Catalent’s Biologics Drug Manufacturing Facility Expansion, Bloomington, USA
Catalent will invest around $350m to expand its biologic drug manufacturing facility in Bloomington, Indiana.
Catalent’s Biologics Manufacturing Facility Expansion, Anagni, Italy
Catalent is expanding its biologics manufacturing facility in Anagni, Italy, with a $100m investment.
Catalent’s Biologics Manufacturing Facility Expansion, Bloomington, Indiana, US
Catalent announced plans to expand its biologics manufacturing facility in Bloomington, Indiana, US
Catalent’s Covid-19 Vaccine Manufacturing Facility, Anagni
Catalent Biologics’ manufacturing facility in Anagni, Italy will serve as the launch facility for the large-scale production and supply of the University of Oxford’s Covid-19 vaccine candidate, AZD1222.
Catalent’s Plasmid DNA Manufacturing Facility, Gosselies, Belgium
Catalent has added a commercial-scale plasmid DNA (pDNA) manufacturing facility to its campus in Gosselies, Belgium.
Cellectis’ Cellular Therapies Manufacturing Facility, Raleigh, North Carolina
Cellectis is building a new facility named Innovative Manufacturing Plant for Allogeneic Cellular Therapies (IMPACT) in Raleigh, North Carolina, US.
Cellipont Bioservices’ Cell Therapy Manufacturing Facility, Houston, Texas
Cellipont Bioservices’ new 76,000ft² manufacturing facility for cell therapies will be located in The Woodlands, Houston.
Celltrion biopharmaceutical plant, Incheon
Celltrion, a joint venture between San Francisco-based Vaxgen and a group of South Korean investors, completed the const
Centocor, a subsidiary of Johnson & Johnson, announced in July 2004 the investment of €500m in the constructio
Central Institute for Translational Cancer Research (TranslaTUM), Technical University of Munich
The Central Institute for Translational Cancer Research (TranslaTUM) is a new interdisciplinary research building at the Technical University of Munich (TUM).
Ceva New Poultry Vaccine Production Facility
Ceva Animal Health (Ceva), a wholly owned US subsidiary of Ceva Santé Animale and a leading player in the global animal
CGT Catapult Manufacturing Facility Expansion
The CGT Catapult Manufacturing Facility, a cell and gene therapy manufacturing facility, in Stevenage in Hertfordshire, UK was expanded in September 2019.
Chao Center for Industrial Pharmacy and Contract
The Chao Center for Industrial Pharmacy and Contract Manufacturing is based in Purdue Research Park, West Lafayette, Indiana and linked to the Purdue University department of Industrial and Physical Pharmacy and Pharmaceutical Sciences.
Charnwood Campus’ Building 42 Research Facility Modernisation, Loughborough, UK
The Charnwood Campus is a life sciences technology park located in Loughborough, UK, which accommodates global MedTech and biopharma companies to promote their business growth.
ChemSyn (Aptuit) Pharmaceutical Manufacturing Plant
ChemSyn Laboratories (now Aptuit), a leading producer of anti-cancer bulk pharmaceuticals and other high potency chemica
Chengdu Vaccine Plant
In early 2007 Technip was awarded a contract by the Chengdu Institute of Biological Products (CDIBP) for the design, con
Children’s Mercy Research Institute, Kansas City, US
Children’s Mercy is building a paediatric research institute at its Adele Hall Campus in Kansas City, Missouri.
China-Biotics, Probiotic Plant, Shanghai
China-Biotics is one of China's largest suppliers of probiotics. In 2009 it opened a bulk additive production facility i
Chugai Pharmaceutical Antibody API Manufacturing Plant, Tokyo, Japan
In October 2015, Japanese pharmaceutical company Chugai Pharmaceutical announced its decision to build a plant for manufacturing antibody active pharmaceutical ingredients (APIs) at its existing Ukima Plant in Kita-ku, Tokyo.
Chugai Pharmaceutical Bulk Antibody
Chugai Pharmaceutical opened the first phase of its antibody production facility in Utsunomiya, Japan, in early 2004, fo
Chugai Pharmaceutical’s New Synthetic Research Facility, Tokyo
Japanese pharmaceutical company Chugai Pharmaceutical is developing a synthetic research facility at its existing location in Kita-ku, Tokyo.
Cincinnati Children’s Hospital Medical Centre Clinical Sciences Building
The construction of a 15-storey clinical science building at Cincinnati Children's Hospital Medical Centre (CCHMC) began in June 2012.
Cipla Biosimilars Manufacturing Facility, Durban, South Africa
India-based pharmaceutical company Cipla has announced plans to build a manufacturing facility in Durban, KwaZulu-Natal, South Africa.
Cipla Medpro Pharmaceuticals, South Africa
Cipla Medpro Pharmaceuticals is listed on the Johannesburg Securities Exchange and is one of South Africa's top ten and
Civica’s Sterile Injectable Manufacturing Facility, Virginia
Civica is building a new manufacturing facility in Petersburg, Virginia for the uninterrupted production and supply of vials and syringes for essential injectable drugs.
Clariant Healthcare Packaging Plant, Cuddalore, Tamil Nadu
In January 2016, Switzerland-based speciality chemical company Clariant broke ground for its new manufacturing and healthcare packaging plant in Tamil Nadu, India.
Clinical and Translational Research Building, University of Florida
The University of Florida started construction of a new clinical and translation research building at its Mowry Road, Gainesville campus in Florida in May 2011.
Clinical and Translational Research Centre, New York
The clinical and translational research centre (CTRC) was inaugurated in September 2012. It is located in the University at Buffalo (UB) medical campus in Buffalo, New York.
Clover Biopharmaceuticals Biomanufacturing Facility, Changxing, China
Chinese biotechnology company Clover Biopharmaceuticals is planning to build a biomanufacturing facility in the Changxing Economic and Technological Development Zone (CETDZ) of Zhejiang, China.
CMC Biologics Seattle Facility Expansion
In August 2010 CMC Biologics completed the first stage of expansion at its site in Bothell near Seattle, Washington, U
Cobra Biologics Manufacturing Facility Expansion, Matfors
Cobra Biologics, a contract development and manufacturing organisation (CDMO), is expanding its manufacturing facility located in Matfors, Sundsvall, Sweden, with an estimated investment of €20m ($22.47m).
Cold Spring Harbour Laboratory Centre for Therapeutics Research, New York
In October 2017, Cold Spring Harbour Laboratory (CSHL) broke ground on its new Centre for Therapeutics Research (CTR) facility in New York.
Columbus Innovation District, Ohio State University
The Columbus Innovation District is a proposed healthcare and technology hub within the Ohio State University in the state of Ohio, US.
Cook Pharmica Biotechnology Plant
Cook Pharmica LLC, the newest Cook Group company, completed the construction of a $70m biotechnology facility in Blo
Coquí RadioPharmaceuticals’ Medical Isotope Production Facility, Florida
In April 2015, Puerto Rican pharmaceutical company Coquí RadioPharmaceuticals (Coquí) completed the schematic design for a medical isotope production (MIP) facility in Alachua County, Florida. Coquí has started work on the detailed design for the facility.
Cordis Corporation Manufacturing Plant, Cashel, Co Tipperary
Cordis Corporation was established in Miami in Florida, US in 1959. The company is a subsidiary of the pharmaceutical major Johnson & Johnson.
Core Technology Facility, University Of Manchester, Manchester
The new Core Technology Facility (CTF) has been opened on the Manchester University campus as a nursery for biotech star
CoreRX Tampa Facility Expansion
US formulation development company CoreRx Pharmaceuticals (CoreRx), initiated a major expansion of its manufacturing sit
CoreRx’s New Product Development Centre, Florida
CoreRx, a contract development and manufacturing organisation (CDMO) based in the US, unveiled a new facility in Clearwater, Florida, in April 2020.
Coriolis Pharma’s ATMP Facility, Martinsried, Germany
Coriolis Pharma opened its new ATMP development facility under biosafety level S2 (BSL2/S2) in February 2022.
Cortex Biotech Facility, Missouri
CORTEX, the Center of Research, Technology & Entrepreneurial Exchange, has constructed a new biotech complex to encourag
CPI Wet Granulation Manufacturing Facility, Durham, UK
In April 2019, Centre for Process Innovation (CPI) announced plans to develop a wet granulation manufacturing facility in Durham, UK.
Croda’s Lipid Systems Manufacturing Facility, Lamar, Pennsylvania, USA
Croda will build a lipid systems manufacturing facility with an investment of up to $133m in Lamar, Pennsylvania, by 2025.
CSL Recombinant Proteins Production Plant, Melbourne, Australia
The CSL Parkville facility has undergone several phases of expansion since 1997 when it was first opened. The production facilities have been expanded three times.
Cubist Pharmaceuticals Facility Expansion, Lexington
US based biopharmaceutical company Cubist Pharmaceuticals owns and operates a lab and research facility in Lexington,
CureVac GMP IV Production Facility, Tubingen, Germany
German pharmaceutical company CureVac is developing a good manufacturing practice (GMP) compliant ribonucleic acid (RNA) production facility at its headquarters in Tubingen, Germany.
Cytiva’s New Manufacturing Facility, Shrewsbury, Massachusetts, USA
Cytiva opened a new facility for manufacturing Xcellerex XDR bioreactors in Shrewsbury, Massachusetts, US, in December 2020.
Daiichi Asubio Pharma New Bio Plant (NBP), Gunma Prefecture
Daiichi Asubio Pharma, a subsidiary of the Daiichi Pharmaceutical Group, opened its New Bio Plant (NBP) at the start of
Daiichi Sankyo Company, Pharmaceutical Plant, Beijing, China
In June 2000, Daiichi Sankyo Company opened a new pharmaceutical plant in Beijing.
Dainippon Sumitomo Pharma’s Chemistry Research Building, Osaka
Dainippon Sumitomo Pharma (DSP) opened a new chemistry research building in Osaka, Japan, in June 2013.
Datwyler’s Elastomer Components Manufacturing Facility, Middletown, Delaware
In December 2016, Datwyler began constructing a new elastomer component manufacturing plant in Delaware, US.
Dendreon Biopharmaceutical Manufacturing Plant, Seattle
Dendreon is a US biotechnology company based in Seattle in the spotlight over its controversial cancer vaccine for the t
Dishman Carbogen Amcis API Facility, Bavla, Ahmedabad, India
Dishman Carbogen Amcis has commissioned its first high-containment API facility at its Bavla site in Ahmedabad, India.
Djavad Mowafaghian Centre for Brain Health, Vancouver
The Djavad Mowafaghian Centre for Brain Health located near the University of British Columbia (UBC) hospital along Wesbrook Mall on the UBC campus in Vancouver, Canada, was inaugurated in February 2014.
Dr Reddy’s Cuernavaca Manufacturing Facility
Dr Reddy's Laboratories launched a new manufacturing facility at its Cuernavaca site in Mexico on 17 March 2010. The fac
DSM Premix Vitamin Plant, Jalisco, Mexico
Hoffman La Roche built a vitamin premix plant in 2000 at El Salto in Jalisco, Mexico, to expand its operations in the premix vitamin market.
Dubai Biotechnology and Research Park (DuBiotech), Dubai, UAE
DuBiotech is the first free zone developed in the Middle East that is dedicated to the life sciences industry.
Duke Research and Discovery @RTP Campus, North Carolina
Duke Research and Discovery @RTP is a new research and discovery hub of the Duke University School of Medicine.
Eastman Chemical Company, Intermediates and Bulk Actives Facility, Arkansas, US
In 1999, Eastman Chemical Company began construction of a small-scale current good manufacturing practice (cGMP) facilit
Eirgenix Protein Drug Production Plant
Eirgenix, a Taiwanese contract development and manufacturing organisation (CDMO), opened a protein drug production plant in Zhubei, Taiwan, in January 2019.
Eisai Centre for Genetics Guided Dementia Discovery, Massachusetts, US
The Eisai Centre for Genetics Guided Dementia Discovery (G2D2) is being developed at the Alewife Research Centre in Cambridge, Massachusetts.
Eisai Knowledge Centre, Visakhapatnam
Eisai Knowledge Centre is located in the Special Economic Zone at the Jawaharlal Nehru Pharma City in Visakhapatnam, Andhra Pradesh, India.
Eisai Parenteral Facility North Carolina
Eisai Inc, a US subsidiary of Japan-based pharmaceutical company Eisai, opened a new parenteral facility in Research Tri
Eisai’s New Oral Solid Dose Production Facility, Suzhou
Eisai China has built a new oral solid dose (OSD) production facility at its new Suzhou plant in China.
Elan Pharma Secondary Pharmaceutical Facility
Elan Pharma is a biopharmaceutical company working in the development of drugs for the treatment of a wide range of ther
Eli Lilly Biotech Pilot Plant, Indianapolis
In October 2006 Eli Lilly completed the first phase of its biotech facility expansion in Indianapolis, which was made re
Eli Lilly Humalog Manufacturing Facility, Carolina
In April 2001 Eli Lilly announced it was constructing a new biotech bulk manufacturing facility in Carolina, Puerto Rico
Eli Lilly Kinsale Pharmaceutical Manufacturing Facility
Eli Lilly made a commitment to invest approximately $400m in a biologics manufacturing facility in December 2006.
Eli Lilly’s New Bio Manufacturing Plant, Cork
Eli Lilly announced the development of a new biomanufacturing plant in Ireland, in February 2012.
Eli Lilly’s Parenteral Product and Device Manufacturing Facility, Concord, North Carolina
Eli Lilly will invest more than $1bn in its second injectable product and device manufacturing facility in North Carolina, US.
Eli Lilly’s Pharmaceutical Manufacturing Facility, Durham, North Carolina
Eli Lilly is building a pharmaceutical manufacturing facility in Durham County, North Carolina, US.
EMD Sereno Research Facility, Massachusetts
EMD Serono, a wholly owned subsidiary of Merck KGaA, which is based in Darmstadt, Germany, launched a new research fac
Emulate’s New Headquarters and Laboratory, Boston, Massachusetts
US-based pharmaceutical company Emulate inaugurated a new headquarters and laboratory in Seaport District in Boston, Massachusetts, in February 2016.
Eskayef Bangladesh, Dhaka, Tongi
Eskayef Bangladesh, also known as Eskayef Pharmaceuticals or SK+F, is one of the largest and fastest expanding pharmaceutical companies located in Tongi, Bangladesh.
European Molecular Biology Laboratory Site, Barcelona
The European Molecular Biology Laboratory (EMBL) is developing a facility within the Barcelona Biomedical Research Park (PRBB) campus in Spain.
Evergreen Theragnostics’ Radiopharmaceutical Manufacturing Facility, New Jersey
Evergreen Theragnostics, a radiopharmaceutical contract development and manufacturing organisation (CDMO) based in New Jersey, US, is developing a state-of-the-art radiopharmaceutical manufacturing facility in New Jersey, US.
Evonik’s New Biomaterials Manufacturing Facility, Birmingham, Alabama
German speciality chemicals company Evonik has launched a new advanced biomaterial manufacturing facility in Birmingham, Alabama, US, in May 2020.
Evonik’s Lipid Production Facility, Lafayette, Indiana, USA
Evonik will build a lipid production facility at its Tippecanoe site in Lafayette, Indiana, with a $220m investment in 2023.
ExoCoBio’s Exosome GMP Manufacturing Facility, Osong, South Korea
ExoCoBio is building the world’s first clinical-grade exosome good manufacturing practice (EGMP) facility in South Korea.
Experic’s Manufacturing and Packaging Facility, New Jersey, USA
Experic plans to build a pharmaceutical research, manufacturing and packaging facility in Cranbury, New Jersey.
Experimental Sciences Building II, Texas Tech University (TTU)
In February 2017, Texas Tech University (TTU), alongside TTU System, started building the Experimental Sciences Building II (ESB-II) at its campus in Lubbock, Texas.
Fermion API Manufacturing Facility Expansion, Hanko
Finland-based pharmaceutical company Fermion is expanding its facility in Hanko, Finland, to increase its manufacturing and commercial production capabilities.
Ferring Pharmaceuticals announced its intention in 2003 to build a new production site at Saint-Prex, Canton of Vaud in
Ferring Pharmaceuticals Biotechnology Centre, Saint-Prex, Switzerland
In February 2018, Swiss biopharmaceutical company Ferring Pharmaceuticals announced plans to build a biotechnology centre at its headquarters in Saint-Prex, Switzerland.
Ferring Pharmaceuticals Freeze Drying
Ferring Pharmaceuticals of Kiel, Wittland, Germany – a subsidiary of Ferring BV of Switzerland – began const
Fiocruz’s Vaccine Manufacturing Centre, Manguinhos, Brazil
In 2001, Brazilian Government institute Fiocruz Instituto de Tecnologia em Imunobiologicos completed one of the largest vaccine manufacturing centres in Latin America.
Forest City Enterprises’ Pharmaceutical Facility in Skokie, Illinois, US
Now owned by Pfizer, Pharmacia Corporation announced in 2000 the opening of its new facility in Skokie in Illinois, US.
Fraunhofer Plant-Based Vaccine Factory
Fraunhofer CMB opened a new cGMP plant-based vaccine facility in Newark, Delaware, in April 2010. The facility is a
Fresenius Kabi’s Pharmaceutical Manufacturing Facility Expansion, Melrose Park, Illinois
In August 2016, German pharmaceutical company Fresenius Kabi announced plans for an expansion of the pharmaceutical manufacturing capabilities of its site in Melrose Park, Illinois.
Fresenius Kabi’s Pharmaceutical Manufacturing Facility Expansion, Wilson, North Carolina
German pharmaceutical firm Fresenius Kabi is expanding its pharmaceutical manufacturing facility in Wilson, North Carolina.
Fujifilm Diosynth Biotechnologies Flexible Biomanufacturing Facility, Texas
Fujifilm Diosynth Biotechnologies (FDB) embarked on an expansion of its flexible biomanufacturing facility at its College Station location in Texas, US, in February 2020.
Fujifilm Diosynth Biotechnologies New Biocampus, Billingham
Fujifilm Diosynth Biotechnologies (FDB) is building a Biocampus at its Billingham, UK site.
Fujifilm Diosynth Biotechnologies’ Advanced Therapies Innovation Centre, College Station, Texas
Fujifilm Diosynth Biotechnologies (FDB) began the construction of its Advanced Therapies Innovation Centre in College Station, Texas, US.
Fujifilm Diosynth Biotechnologies’ Biologics Production Facility Expansion
Fujifilm Diosynth Biotechnologies (FDB), a subsidiary of Japanese multinational conglomerate Fujifilm, is expanding its large-scale biologics production facility in Hillerod, Denmark.
Fujifilm Diosynth Biotechnologies’ Biomanufacturing Facility Expansion
Fujifilm Diosynth Biotechnologies is expanding its existing BioProcess Innovation Center in North Carolina, US.
Fujifilm Diosynth Biotechnologies’ Cell Culture Manufacturing Facility, North Carolina
Fujifilm Diosynth Biotechnologies (FDB), a subsidiary of Japanese conglomerate Fujifilm, is building a new cell culture manufacturing facility in Holly Springs, North Carolina, US.
Fujifilm’s Cell Culture Media Manufacturing Facility, Netherlands
Fujifilm opened a new cell culture media production facility in Tilburg, the Netherlands, in December 2021.
Fulton Labs, Chicago
Fulton Labs is a new laboratory facility being developed in Chicago, Illinois, US, the first life science laboratory space in Chicago's Fulton Market.
GE Healthcare Biopharmaceutical Campus, Cork County, Ireland
Multinational healthcare service provider GE Healthcare has announced plans to invest $170m to develop a biopharmaceutical campus in Cork County, Ireland.
GE Healthcare Biotechnology Manufacturing Centre, Stevenage, UK
In November 2018, GE Healthcare opened a new manufacturing centre in Stevenage, UK. The facility is scheduled to open for commercial operations in the first half of 2019.
GE Healthcare Pharmaceutical Manufacturing Plant, Shanghai, China
In 2000, Nycomed Amersham announced it would open a new pharmaceutical plant in Shanghai on 27 October.
GE Healthcare Viral Vector Manufacturing Facility, Worcester
GE Healthcare (GEHC) Life Sciences and the University of Massachusetts Medical School (UMMS) unveiled plans to set up a manufacturing facility for gene therapy in Worcester, US, in December 2019.
GE Healthcare’s Manufacturing Facility, Grens
GE Healthcare is building a manufacturing facility for cell processing kits in Grens, Switzerland.
GEA Niro Pharmaceutical Spray Drying Facility, Copenhagen
GEA Niro's GMP pharmaceutical spray drying facility is part of the company's Test Centre located in Copenhagen, Denmark.
Gedeon Richter Biopharmaceutical Plant, Debrecen, Hungary
In July 2008, Gedeon Richter, one of Hungary's largest pharmaceutical companies, started building a facility for the development and manufacture of biopharmaceutical products in Debrecen.
Gemini Bio’s New Manufacturing Facility, West Sacramento
Cell culture solutions provider Gemini Bioproducts (Gemini Bio) opened its new manufacturing facility in West Sacramento, California, US, in June 2020.
Genentech Cell Culture Plant No 2 Expansion
Genentech is one of the most successful biotech companies on a world scale with four drugs prominent on the commercial m
Genentech Inc Fill and Finish Facility
Genentech is one of the leading biotechnology corporations in the US, with facilities around the world and more than 10,
Genentech Manufacturing Facility (NIMO)
The NIMO (New Idec Manufacturing Operation) in Oceanside, San Diego, was originally built by Idec as the company wanted
Genentech Singapore Biologics Plant
Lonza Biologics Singapore has built a large-scale cell culture manufacturing facility in Singapore's Tuas Biomedical Par
Genentech’s Biologics Manufacturing Facility, Oceanside, California, USA
Genentech’s first-of-its-kind commercial biologics manufacturing facility in Oceanside will be operational in 2025.
GenScript’s Biologics Manufacturing Centre, Zhenjiang
GenScript Biotech is constructing a biologics manufacturing centre in Zhenjiang city, Jiangsu Province, China.
Genzyme Biomanufacturing Plant
In June 2007, Genzyme Corporation announced the construction of a new biomanufacturing plant in Lyon, France. The compan
Genzyme Flanders NV, Biopharmaceutical Plant Expansion, Geel
Genzyme Flanders is a European subsidiary of the US biotech giant Genzyme Corporation. The 70,000ft² facility in Ge
Genzyme Manufacturing Expansion
Genzyme Corporation is one of most prominent biotechnology companies in the US. Based in Cambridge, Massachusetts, it wa
Genzyme Manufacturing Expansion, Waterford
Genzyme Corporation is one of the world's leading biotech manufacturers and announced the establishment of a manufacturi
Genzyme R&D Facility
Genzyme, the third largest biotechnology company in the world by sales, is constructing a new research and development
Genzyme Science Center Framingham, Massachusetts, USA
Genzyme Corporation is one of the world's leading biotechnology companies, which has been in operation since 1981. G
Gibbs Cancer Centre and Research Institute, Pelham, South Carolina
Gibbs Cancer Centre and Research Institute began building a $65m facility in Pelham, North Carolina, with an official ground-breaking ceremony held on 17 May 2016.
Glaxo Wellcome Anti-Infective Drugs Plant, Suzhou, China
In 1998, Glaxo Wellcome made an investment in a production facility in Suzhou in the eastern Chinese province of Jiangsu.
GlaxoSmithKline Antibiotic Plant Expansion, Irvine, Scotland
GlaxoSmithKline (GSK) opened its expanded antibiotics facility in Irvine, Scotland, in February 2016.
GlaxoSmithKline Manufacturing and Packaging Plant, Zebulon, NC
In 1999, UK-based pharmaceuticals company Glaxo Wellcome instigated a project to expand its 652,000ft² manufacturing and packaging plant in Zebulon, NC.
GlaxoSmithKline Manufacturing Facility Expansion, Boronia
GlaxoSmithKline (GSK) announced the expansion of its manufacturing facility in Boronia, in the outer eastern suburbs of Melbourne, Australia, in November 2014.
GlaxoSmithKline Vaccine Manufacturing Facility, Tuas
GlaxoSmithKline (GSK) has had a presence in Singapore since the 1970s with its investment in an antibiotics plant. Since
GlaxoSmithKline’s (GSK) Pharmaceutical Tablet Manufacturing Factory, Karnataka
GlaxoSmithKline (GSK) began construction of an oral solid-dose manufacturing plant at the Vemgal Industrial Area in India in September 2015.
Glycotope Biotechnology Antibody Production Facility
Glycotope Biotechnology, a wholly owned subsidiary of Glycotope GmbH, operates an antibody production facility in Heid
Grail’s RTP Cancer Test Manufacturing Facility, North Carolina
US-based healthcare company Grail is building a state-of-the-art laboratory facility in the Research Triangle Park (RTP), North Carolina. The facility will primarily function as a commercial cancer lab for sample processing.
GRAM’s Pharmaceutical Manufacturing Facility, Michigan, US
Opened in June 2020, GRAM’s third injectable fill/finish facility tripled its existing footprint in Grand Rapids, Michigan.
Green Cross Biotherapeutics’ Biomanufacturing Facility, Montreal
In June 2015, biopharmaceutical company Green Cross Biotherapeutics (GCBT) broke ground on the construction of Canada’s first intravenous immunoglobulin (IVIG) and albumin manufacturing plant in Montreal, Quebec.
Grifols’ North Fractionation Facility (NFF), Clayton
North Fractionation facility (NFF), a new plasma fractionation plant, was inaugurated by Grifols in June 2014 at Clayton in North Carolina, US.
Grindeks Final Dosage Forms Facility, Riga
Grindeks is one of the leading pharmaceutical companies in the Baltic States and its main areas of activity are heart an
Grindeks Ursodeoxycholic Acid Manufacturing Plant
Latvia-based Grindeks opened a new active pharmaceutical ingredient (API) manufacturing unit in Riga in June 2011.
GSK Biologicals Manufacturing Plant
The vaccine manufacturing plant of GlaxoSmithKline (GSK) in Dresden, Germany mainly produces the company's seasonal infl
GSk Vaccine Manufcaturing Plant, St Amand Les Eaux
GSK Biologicals, the vaccine division of the pharmaceutical and healthcare company GlaxoSmithKline (GSK), announced its
GSK’s New Biopharmaceutical Plant, Ulverston
GlaxoSmithKline (GSK) unveiled plans for the construction of a new biopharmaceutical plant in the UK in February 2014.
Gulf Pharmaceutical Industries (Julphar) Insulin Production Facility
Gulf Pharmaceutical Industries, known popularly as Julphar, is set to inaugurate the first ever insulin production facility in the Middle East.
GVK Biosciences’ Clinical Pharmacology Unit
GVK Biosciences, a contract research organisation based in the city of Hyderabad, India, operates a clinical pharmaco
H3 Biomedicine New Research Facility
H3 Biomedicine, the American subsidiary of Tokyo-based company Eisai, opened its new research facility in Cambridge, in the state of Massachusetts, US, in December 2011.
HALIX cGMP Biopharmaceutical Facility, Leiden
HALIX inaugurated its new current good manufacturing practice (cGMP) biopharmaceutical manufacturing facility at the Leiden Bioscience Park, Netherlands, in November 2019.
Halo Pharmaceuticals Whippany Facility
Halo Pharmaceuticals' Whippany facility is a cGMP compliant pharmaceutical manufacturing and packaging plant. The faci
Hameln Pharma Sterile Facility
Contract manufacturer hameln pharma's sterile production facility at Hameln, Germany was built to enhance the production
Hanmi Pharmaceutical Bio Manufacturing Plant, Pyeongtaek
Korea-based pharmaceutical company Hanmi Pharmaceutical is building a biologics manufacturing facility in Pyeongtaek in the Gyeonggi province of South Korea.
Haupt Pharma, New Packaging Line
Haupt Pharma is one of the world's largest contract manufacturers of pharmaceuticals. With nine production sites across
Health Sciences Biomedical Research Facility, UCSD, California
In March 2014, the University of California, San Diego (UCSD), opened a health sciences biomedical research facility in La Jolla, California.
Helsinn New Cytotoxic Plant, Biasca
Switzerland-based pharmaceutical ingredient manufacturer Helsinn expanded its Biasca site in Switzerland with a new cytotoxic API manufacturing facility.
Hermes Pharma Production Plant, Wolfsberg, Austria
Hermes Pharma GmbH has developed and produced compounds at its Wolfsberg plant in Austria since 2003. The company also h
Hitachi Chemical’s Cell and Gene Therapy Manufacturing Facility, New Jersey
Hitachi Chemical Advanced Therapeutics Solutions (HCATS) opened its new manufacturing facility in New Jersey, US, in January 2020, developed to meet the demand for cell and gene therapy manufacturing services.
Hoffman La Roche Biotechnology Plant Expansion, Penzberg, Upper Bavaria
Hoffman La Roche, the Swiss biotech company, began expanding its biotech production capacity in 2004 with the constructi
Hovione API Facility Expansion, East Windsor, New Jersey
Portugal-based pharmaceutical company Hovione is expanding its active pharmaceutical ingredient (API) facility in East Windsor, New Jersey.
Hovione Manufacturing Plant, Loughbeg, County Cork
The production plant at Loughbeg in County Cork, Ireland, is currently owned by Hovione.
Hovione’s Continuous Manufacturing Facility, Loures, Portugal
Hovione has expanded its continuous tableting capacity with a state-of-the-art manufacturing facility at its site in Loures, Portugal.
Hovione’s Pharmaceutical Manufacturing Facility Expansion, East Windsor, New Jersey
Hovione's New Jersey pharmaceutical campus will have additional commercial spray drying manufacturing capacity added by 2023.
Huntsman Cancer Institute Expansion, Utah
The Huntsman Cancer Institute (HCI) is a part of the University of Utah campus in Salt Lake City, Utah.
IC Asia Pharmaceutical Plant
IC AsiaCo Ltd (Indochina Co Ltd), a subsidiary of Indochina Pharmaceutical Co., Ltd, began construction on the Dong103bn
IDT Biologika Live Human Viral Vaccine Production Facility
IDT Biologika is one of the leading biotechnology companies in Germany with its origins in the Bacteriological Institute
IDT’s New Manufacturing Facility, North Carolina
Integrated DNA Technologies (IDT) opened a manufacturing facility in North Carolina's Research Triangle Park in the US in May 2020 for supporting research and testing efforts related to the Covid-19 pandemic.
ILC Dover Manufacturing Facility
In May 2019, ILC Dover opened a manufacturing facility in Ireland to produce the company’s pharmaceutical and biopharmaceutical product lines. The plant is designed to strengthen the company's single-use powder handling solutions business.
Imaging Centre of Excellence, University of Glasgow, Scotland
In March 2017, the Imaging Centre of Excellence (ICE) at the Queen Elizabeth University Hospital (QEUH) in Scotland was inaugurated.
ImClone Systems Biopharmaceutical Plant, New Jersey, US
In January 2000, ImClone Systems began construction of a new 100,000ft² biopharmaceutical manufacturing facility in Branchburg, New Jersey.
Indena Anti-Cancer Compound Plant Automation
Indena SpA, an Italian company based in Settala near Milan, has announced plans to automate its plant for the production
Inhalable Insulin Manufacturing Facility, Frankfurt, Germany
In early November 1998, Hoechst Marion Roussel (HMR) and Pfizer announced their intention to jointly develop, produce and sell inhalable insulin on a global scale.
International Stem Cell Corporation Stem Cell Manufacturing Facility
The International Stem Cell Corporation (ISCO) launched its new Oceanside stem cell manufacturing facility in February
InterVac, University of Saskatchewan
In September 2011, the University of Saskatchewan opened a new vaccine research and development (R&D) centre at its campus in Saskatoon, Canada.
Iovance Biotherapeutics Cell Therapy Production Facility
In May 2019, Iovance Biotherapeutics announced its plans to build a cell therapy production facility in Philadelphia, US.
Iroko Pharmaceuticals Global Headquarters, Philadelphia
Iroko Pharmaceuticals inaugurated its new global corporate headquarters in December 2012 at Navy Yard Corporate Centre in Philadelphia, USA.
Isis Pharmaceuticals New R&D Facility, California
Isis Pharmaceuticals inaugurated a new research and development (R&D) facility at Carlsbad in California, USA in September 2011. The new facility is provided with sophisticated drug discovery and development facilities.
James L. Sorenson Molecular Biotechnology Building, Utah
University of Utah's new innovation centre, the James L. Sorenson Molecular Biotechnology Building, was officially dedicated in April 2012.
Janssen Pharmaceutica’s Pharmaceutical Plant, Geel, Belgium
Johnson & Johnson (J&J) subsidiary Janssen Pharmaceutica decided to build a new pharmaceutical plant in Geel in Belgium in 1998.
Janssen Sciences’ Biomedicines Manufacturing Facility, Ringaskiddy, Ireland
Janssen Sciences Ireland has expanded its biomedicines manufacturing facility in Barnahely, Ringaskiddy in County Cork, Ireland, with the addition of the BioCork II manufacturing building.
Jazz Pharmaceuticals Development and Manufacturing Facility, Athlone
Ireland-based biopharmaceutical company Jazz Pharmaceuticals has opened a manufacturing facility in Athlone, Ireland.
JC Wilt Infectious Diseases Research Centre, Winnipeg
The Public Health Agency of Canada (PHAC) opened a new infectious diseases research centre at 745 Logan Avenue in the Winnipeg city of Manitoba province, Canada, in February 2014.
Jennie Smoly Caruthers Biotechnology Building, Colorado
University of Colorado's Jennie Smoly Caruthers Biotechnology Building (JSCBB) was opened in April 2012. It has been built with an investment of $160m.
JHL Biotech Biosimilars Manufacturing Facility, Wuhan, China
In May 2016, Taiwan-based biopharmaceutical company JHL Biotech officially inaugurated a single-use bioprocessing technology-based KUBio™ modular biopharmaceutical manufacturing facility in Wuhan, China.
JHP Pharmaceuticals Manufacturing Facility
JHP Pharmaceuticals, a maker of sterile injectable products, owns and operates a manufacturing site in Rochester, Mi
Jill and John Freidenrich Center for Translational Research (FCTR), Stanford University
The Jill and John Freidenrich Center for Translational Research was officially opened in October 2012.
Jinyu Bio-technology Research Facility, Kansas
In May 2017, Chinese animal vaccine company Jinyu Bio-technology unveiled plans to establish its first US-based vaccine research lab and office facility, located in Kansas.
John and Editha Kapoor Hall, University at Buffalo, US
John and Editha Kapoor Hall is located on the south campus of the University at Buffalo in New York, United States. It houses the School of Pharmacy and Pharmaceutical Sciences.
John Edward Porter Neuroscience Research Center, Maryland
The John Edward Porter Neuroscience Research Centre in Bethesda, Maryland, was opened and dedicated to the public in March 2014.
Jubilant HollisterStier’s Sterile Injectable Manufacturing Facility Expansion, Spokane, US
US-based contract pharmaceutical manufacturer Jubilant HollisterStier is expanding the sterile injectable production capacity at its facility in Spokane, Washington.
Julphar Manufacturing Facility, Addis Ababa
UAE-based pharmaceutical firm Gulf Pharmaceutical Industries (Julphar) officially opened a new pharmaceuticals manufacturing facility in February 2013.
Juno Therapeutics Headquarters and R&D Facility, Washington
In September 2017, Juno Therapeutics has inaugurated a research and development (R&D) facility in Seattle, Washington, with a $232m investment.
KBI Biopharma, North Carolina Center For Biomanufacturing, Durham, North Carolina
KBI BioPharma, a division of Atlanta-based Kinetic Biosystems Inc, decided in late 2003 that the home of its new contrac
KBI Biopharma’s Biologics Manufacturing Facility, North Carolina, USA
KBI Biopharma has opened a 150,000ft² biologics manufacturing facility in Durham, North Carolina.
Kemwell Biopharmaceutical Manufacturing Facility, Bangalore
Kemwell is building a new biopharmaceutical manufacturing facility in Bangalore, India. The green-field site will be c
Kemwell Pharmaceutical Manufacturing Facility
India-based contract manufacturer Kemwell launched a new solid and semi-solid pharmaceutical manufacturing facility in
Kilitch Drugs Manufacturing Plant
Indian pharmaceuticals manufacturing company Kilitch Drugs produces and markets drug formulations in solid, liquid and parenteral dosage forms.
Kite Pharma’s CAR T-cell Therapy Production Facility, Maryland
In April 2019, Kite Pharma announced plans to develop a new chimeric antigen receptor (CAR) T-cell therapy production facility in Maryland, US.
Kite Pharma’s Biopharmaceutical Manufacturing Facility
Kite Pharma, a subsidiary of Gilead Sciences, announced about the construction of its new biopharmaceutical manufacturing facility in Hoofddorp, the Netherlands.
Kite Pharma’s Viral Vector Manufacturing Facility, California
Kite Pharma, a subsidiary of Gilead Company, announced plans to build a new viral vector manufacturing facility in Oceanside, California, US, in July 2019.
Knight Cancer Institute Research Building, Oregon
Oregon Health and Science University’s (OHSU) Knight Cancer Institute has built a research building at South Waterfront district in south-west Portland, Oregon.
Kondirolli Pharmaceutical Facility, Pristina
When the war in Kosovo ended in June 1999 the country, including its capital Pristina, was in a terrible state. Out of a
Krka, a Slovenian pharmaceutical company, opened a new solid dosage forms production facility in Istra, northwest Moscow
Krka Notol Pharmaceutical Plant
Krka is a major pharmaceutical and chemical products supplier based in Novo Mesto in Southern Slovenia on the Krka River
KwaZulu-Natal Research Institute for Tuberculosis and HIV, Durban
KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) is located in Durban, South Africa. K-RITH was founded in 2008 by the Howard Hughes Medical Institute (HHMI) and the University of KwaZulu-Natal (UKZN).
LabCentral 238, Cambridge, Massachusetts, USA
LabCentral 238 in Cambridge, Massachusetts, will be fully opened in 2022 after the completion of its second phase.
Lakes BioScience’s New Biomanufacturing Plant, Ulverston
Lakes BioScience is planning to build a pharmaceutical manufacturing plant in Ulverston, Cumbria, UK. The new facility will be built as part of the company’s Project Apex, an initiative to create a customer-focused contract development and manufacturing organisation (CDMO).
Leaf Systems Bioscience Research Facility, Norfolk
Leaf Systems International has opened a bioscience research and development (R&D) facility at the Norwich Research Park in Norfolk, UK.
LG Chemical Pharmaceutical Plant, Iksan, South Korea
The LG Chemical Pharmaceutical Plant is owned by Lucky Goldstar Chemical (LG Chemical), a sub-division of one of South Korea's best-known chaebols (business groups).
Lilly Institute for Genetic Medicine, Boston, Massachusetts, USA
The Lilly Institute for Genetic Medicine, being developed by Eli Lilly, will focus on developing RNA-based therapies.
Lonza Biologics Facility, Guangzhou, China
Lonza and GE Healthcare are developing a biologics facility in Guangzhou, China.
Lonza Biologics Plant Expansion
Lonza Biologics completed the large-scale expansion of their facility in Portsmouth, New Hampshire, Pease International
Lonza Biotec completed the construction of new manufacturing capacity with a multi-product design at Visp in Switzerland
Lonza cGMP Manufacturing Facility, Slough
Lonza operates a cGMP manufacturing facility in Slough, UK. Located close to Heathrow Airport in London in the Thames Va
Lonza Houston’s Biotech Facility, Pearland, Texas
In April 2018, viral and cell therapy manufacturer Lonza Houston finished building a biotech facility for immunotherapy development and manufacturing in Pearland, Texas.
Lonza Niacinamide Production Facility, Iksan, South Korea
Lonza Fine Chemicals and Specialties put a production facility for niacinamide into operation in 1997 following a joint venture (JV) agreement with the Guangzhou Pesticide Factory.
Lonza’s Ibex Biomanufacturing Complex, Visp, Switzerland
Lonza has developed a new biomanufacturing complex at its biopark in Visp, Switzerland.
Lonza’s Bioconjugation Facility Expansion, Visp
Lonza announced the expansion of its bioconjugation facility at Visp, Switzerland in December 2020.
Lotus Pharmaceuticals Facility
China-based prescription drug developer and pharmaceutical manufacturer Lotus Pharmaceuticals is constructing a new he
Louis A Simpson and Kimberly K Querrey Biomedical Research Centre, Northwestern University
Construction of the Louis A Simpson and Kimberly K Querrey Biomedical Research Centre at Northwestern University Feinberg School of Medicine in Chicago, Illinois, began in May 2015.
Louisiana Cancer Research Centre, New Orleans
The construction of the Louisiana Cancer Research Center was initiated in April 2009 and completed by 2012.
Lowy Cancer Research Institute
The Lowy Cancer Research Institute, located in the premises of University of New South Wales (UNSW), Sydney, is the largest cancer research centre in southern Australia.
LS Skaggs Pharmacy Institute, University of Utah, Salt Lake City
The LS Skaggs Pharmacy Institute is a research facility opened in April 2013 for the College of Pharmacy at the University of Utah in Salt Lake City, Utah.
Lykan Bioscience’s SMART Manufacturing Facility, Hopkinton, Massachusetts
Lykan Bioscience opened a purpose-built SMART Manufacturing™ facility for developing cell-based therapies in Hopkinton, Massachusetts, US, in September 2020.
MannKind’s Afrezza Manufacturing Facility, California
MannKind Corporation is a bio-pharmaceutical firm located in the city of Santa Clarita, California, in the US.
Mapi Pharma’s Sterile Injectable Production Plant in Jerusalem
Israel-based clinical-stage pharmaceutical company Mapi Pharma has announced the development of a new sterile injectable production plant in Jerusalem.
Marine Biological Laboratory’s Loeb Lab Renovation
Marine Biological Laboratory (MBL) is an internationally recognised not-for-profit research, education and training institute for environmental, biomedical and biological sciences.
Masy Systems Biorepository
The importance of custom cell lines and biological samples for use in biotechnology manufacturing is increasing. To keep
Max Planck Florida Institute (MPFI), Jupiter, Florida
Germany-based Max Planck Society opened its new biomedical research facility, the Max Planck Florida Institute (MPFI), in June 2012.
Mayne Pharma’s Oral Solid Dose Manufacturing Facility, Greenville, North Carolina
Australian pharmaceutical company Mayne Pharma has opened an oral solid dose (OSD) commercial manufacturing facility in Greenville, North Carolina.
Medicago cGMP Vaccine Facility
Canada-based pharmaceutical company Medicago broke ground for the construction of a new influenza vaccine production pla
Medicago’s Vaccine Production Facility, Quebec, Canada
Medicago is constructing a new influenza vaccine production facility in the Estimauville Innovation Area in Quebec City, Canada.
Medical and Research Translation (MART) Building, Stony Brook University
Construction of the Medical and Research Translation (MART) building at the Stony Brook University (SBU) medical centre campus began in November 2013.
Medicines Manufacturing Innovation Centre, Renfrewshire, Scotland
The Centre for Process Innovation (CPI) is building the Medicines Manufacturing Innovation Centre in Renfrewshire, Scotland.
Medimmune, Biologics Manufacturing Facility
In September 2006 MedImmune, a Maryland-based biologics company working in the areas of infectious diseases, cancer and
Medis International Drug Packaging Plant
Medis International opened a new drug packaging plant in Bolatice, Czech Republic, in December 2009. Construction was co
Medlac Pharmaceutical Plant
Medlac is an Italy-based pharmaceutical company specialising in dermatological products. The company officially inaugurated a new 10,000m² manufacturing plant in Vietnam in April 2011.
Meissner Filtration Products’ Manufacturing Facility, Castlebar, Ireland
Meissner Filtration Products is developing a new manufacturing facility in County Mayo, Castlebar, Ireland.
Merck And Co Vaccine Facility, Carlow, Ireland
Merck Sharpe and Dohme, the world's seventh largest pharmaceutical company, has a highly successful vaccine division
Merck Biotech Development Facility, Corsier-sur-Vevey, Switzerland
Merck’s new biotech development facility in Corsier-sur-Vevey, Switzerland, is expected to begin full-scale operations by 2023.
Merck Frosst Centre for Therapeutic Research
Merck Frosst's Kirkland facility is the oldest and the largest biomedical research facility in Canada. Established in
Merck Innovation Center, Darmstadt
Merck KGaA’s innovation centre at its global headquarters in Darmstadt was built as a part of a €1bn ($1.12bn) strategic initiative.
Merck Pharmaceutical Manufacturing Facility Expansion, Molsheim, France
Merck will expand its manufacturing capabilities in Molsheim, France, with an investment of more than €130m ($129.1m).
Merck Serono Biopharmaceutical R&D Facility Expansion, Darmstadt
In September 2015, Merck Serono began an expansion of its research and development (R&D) facility within the new Pharma Square on its campus in Darmstadt, Germany.
Merck Serono’s Pharmaceutical Manufacturing Facility, Nantong, China
The Nantong facility is one of Merck's largest pharmaceutical manufacturing plants in the world.
Merck Sharpe & Dohme Formulation Plant
Merck Sharpe & Dohme, known as MSD Technology Singapore Pte Ltd in Singapore, opened their newest manufacturing facility
Merck Vaccine Plant, Durham, NC, USA
Merck's 272,000ft² vaccine production plant is located on a 262-acre site in Treyburn Corporate Park on the north s
Merck’s Pharmaceutical Packaging Facility, Hangzhou
Merck officially inaugurated a new drug packaging facility at Hangzhou in April 2013. The new plant is located in the Hangzhou Economic and Technology Area (HEDA) in Hangzhou.
Merck’s ADC Manufacturing Facility Expansion, Madison, Wisconsin, USA
Merck announced the expansion of its high-potent active pharmaceutical ingredient (HPAPI) and antibody-drug conjugate (ADC) production capabilities and capacity at its facility in Madison, Wisconsin, US, in September 2020.
Merck’s Biodevelopment Centre Expansion, Martillac, France
Merck has expanded its site in Martillac, France, by adding a commercial facility for manufacturing drug substances.
Merck’s Biotech Manufacturing Facility Expansion, Aubonne, Switzerland
In March 2019, Merck announced plans to expand its biotech manufacturing facility in Aubonne, Switzerland.
Meridian Life Science Biopharmaceutical Facility
Meridian Life Science is a premier manufacturer of critical reagents for the in-vitro diagnostic industry and a contrac
Merrion Biopharma Research and Development Laboratories
Merrion's new R&D facility located in Citywest, south Dublin, Ireland is a state-of-the-art facility designed to accommo
Metrics’ Oral Solid-Dose Commercial Facility Expansion, North Carolina
Metrics added 3,760ft² of manufacturing space and equipment to its oral solid-dose commercial facility in July 2021.
Michael J Fox Foundation for Parkinson’s Disease Research, New York, US
The Michael J Fox Foundation for Parkinson's Research aims to encourage the development of therapies to treat Parkinson's disease.
Michael Uren Biomedical Engineering Research Hub, London
The Michael Uren Biomedical Engineering Research Hub is a state-of-the-art laboratory and office facility being developed at the Imperial College London campus in White City, London.
Michigan State University Bioengineering Facility, East Lansing, Michigan
Michigan State University (MSU) has opened a bioengineering facility at its campus in East Lansing, Michigan.
MilliporeSigma Life Science Campus, Burlington, Massachusetts
In October 2017, MilliporeSigma, the life sciences division of Germany-based science and technology firm Merck, opened a life science campus in Burlington, Massachusetts.
MilliporeSigma’s M Lab Collaboration Center, Shanghai
MilliporeSigma opened its new M LabTM Collaboration Center in Shanghai in July 2020, the company’s largest such centre to date.
Minakem’s High-Containment Production Facility, Louvain-la-Neuve, Belgium
In the second half of 2018, Minakem opened a new high-containment production facility in Louvain-la-Neuve, Belgium.
Moderna mRNA Vaccine Manufacturing Facility, Quebec, Canada
Moderna’s new mRNA vaccine manufacturing facility in Quebec is intended to strengthen Canada’s readiness to deal with pandemics.
Moderna Science Centre, Cambridge, Massachusetts
Moderna’s science centre will serve as its new headquarters and support the company’s future research and discoveries.
Moderna Therapeutics Clinical Manufacturing Facility, Massachusetts, USA
Moderna opened a GMP clinical manufacturing facility in Norwood, Massachusetts, in July 2018 with a $110m investment.
Moderna’s mRNA Vaccine Manufacturing Facility, UK
Moderna’s state-of-the-art mRNA Innovation and Technology Centre will produce up to 250 million vaccine doses a year.
Morphotek’s New Biologics Production Facility
Morphotek, a subsidiary of Eisai Co, opened a pilot manufacturing plant for the production of antibodies for early phase clinical trials of biologics in Welsh Road, Exton, Pennsylvania, US, in August 2012.
MSD Biologics Advanced Biologics Centre
Avecia Biotechnology announced a $100m investment in a new advanced centre for biologics manufacture in Billingham,
MSD’s Manufacturing Plant Expansion, Ballydine Co Tipperary, Ireland
Between 1997 and 1999, Merck Sharp and Dohme (MSD) undertook a two-year expansion of its manufacturing facility in Ballydine Co Tipperary, Ireland.
MSD’s Biologics Manufacturing Facility, Swords, Ireland
In February 2018, US-based pharmaceutical company Merck Sharp and Dohme (MSD) announced its plans to develop a biologics manufacturing facility in Dublin, Ireland.
MSU Grand Rapids Research Centre, Michigan, USA
The Grand Rapids Research Centre at Michigan State University was opened in September 2017.
Mubadala’s Biopharma Manufacturing Facility, Abu Dhabi, UAE
Mubadala will build the first GMP biopharma manufacturing facility in Abu Dhabi to boost the UAE's life sciences ecosystem.
NanoViricides cGMP Production Plant, Shelton, Connecticut
In August 2013, NanoViricides began building a clinical-scale current good manufacturing practice (cGMP) production plant at the industrial-commercial zone on the Route 8 Corridor in Shelton City, Connecticut.
NantWorks Pharmaceutical Manufacturing Plant, Indiana
NantWorks, a US-based pharmaceutical company, announced it was to setup a new drug manufacturing plant in Vigo County, in the state of Indiana, in January 2012.
National Biologics Manufacturing Centre, Darlington
Construction of the National Biologics Manufacturing Centre at Central Park in Darlington, UK, began in April 2014.
National Biomanufacturing Centre
The National Biomanufacturing Centre (NBC) is a biotech plant constructed on a 60,000ft² plot on the Estuary Commer
Navesta Pharmaceuticals’ Sterile Pharmaceutical Manufacturing Plant, Horana
In August 2017, Sri Lanka-based pharmaceutical company Navesta Pharmaceuticals opened a sterile manufacturing facility in the town of Horana.
Neopharma Pharmaceutical Plant, Abu Dhabi, UAE
Neopharma’s pharmaceutical plant in Abu Dhabi produces 300 types of drugs and medicines under various brands.
Neuroscience Building, University of Miami
The University of Miami began construction of a new neuroscience facility at the Coral Gables campus in April 2012.
Neurosciences Research Building, Indiana University, Indianapolis
Construction of a new neurosciences research building at Indiana University (IU) in Indianapolis, US, was initiated in August 2012.
New Orleans BioInnovation Center
New Orleans BioInnovation Center (NOBIC) is located on Canal Street in New Orleans, US. It was opened in June 2011 and officially inaugurated in September 2011.
NextPharma Clinical Trial Services Facility, Gottingen
NextPharma's Clinical Trial Services (CTS) facility in Gottingen, Germany, launched in December 2008. The facility is an
NextPharma San Diego Facility
NextPharma's San Diego facility in California, USA, is a cGMP contract manufacturing facility serving companies in the b
NextPharma SVA Facility
UK-based contract manufacturer NextPharma's plant in Braine-l'Alleud, Belgium specialises in the production and packagin
Nexus Pharmaceuticals’ Sterile Injectable Manufacturing Facility, Pleasant Prairie, USA
Nexus’ sterile injectable manufacturing facility in Wisconsin will be fully developed with a $250m investment in ten years.
Nippon Shinyaku Corporation, Pharmaceuticals Formulation Production Plant, Odawara, Japan
The Nippon Shinyaku Corporation's pharmaceuticals formulation production plant Odawara, Japan, began construction in January 2000 and was completed in February 2001.
NJ Biopharmaceuticals’ Manufacturing Facility and Headquarters, Princeton, New Jersey
NJ Biopharmaceuticals will open a facility in Princeton to provide GMP manufacturing capabilities to clients for antibody drug conjugates.
Northeast Texas Cancer and Research Institute, Tyler, Texas
The Northeast Texas Cancer and Research Institute is being built within the CHRISTUS Trinity Mother Frances hospital complex in Tyler.
Norwich Pharmaceuticals Norwich Facility
A leading provider of contract manufacturing and packaging services, Norwich Pharmaceuticals has served the pharmaceutic
Nova Southeastern University (NSU) Centre for Collaborative Research
Nova Southeastern University (NSU) has opened the Centre for Collaborative Research (CCR) on its main campus in Davie, Florida.
NovaMedica Pharmaceutical Plant, Kaluga
In May 2017, Russian pharmaceutical company NovaMedica began building a pharmaceutical manufacturing plant for sterile injectable drugs at the Vorsino Industrial Park, Kaluga, Russia.
Novartis Biomanufacturing Plant
Novartis is a multinational pharmaceutical company, based in Basel in Switzerland. The company has plants situated acros
Novartis Biotechnology Centre Expansion, Huningue
Swiss pharmaceutical company Novartis is carrying out a major expansion of its biotechnology centre in Huningue, France.
Novartis Diovan Manufacturing Plant, Schweizerhalle, Switzerland
In September 1999 Novartis opened a new pharmaceutical production facility at the Schweizerhalle site near Basel, Switzerland.
Novartis Institute of BioMedical Research
The Novartis Institute of BioMedical Research (CNBIR) is located in the Zhangjiang High-Tech Park in the Pudong New Area
Novartis Pharmaceutical Development Centre
On 2 November 2009, Novartis officially opened its new global technical centre Suzhou Novartis Pharma Technology Co in R
Novartis Pharmaceutical Manufacturing Plant, St Petersburg, Russia
In June 2011, Swiss pharmaceutical company Novartis began building a pharmaceutical manufacturing facility in St Petersburg, Russia.
Novartis Stein Cell and Gene Therapy Facility
Novartis opened its new cell and gene therapy facility in Stein, Switzerland, in November 2019. The site is intended to support the production of innovative medicines.
Novartis Vaccine Manufacturing Facility
Novartis has begun production at its new vaccine manufacturing facility in Marburg, Germany in April 2011. The plant produces rabies and tick-borne encephalitis (TBE) vaccines.
Novartis Vaccine Manufacturing Facility, North Carolina
In July 2006 Novartis announced that it would build a new vaccine manufacturing facility in Holly Springs, North Carolina, US.
Novartis’ API Plant in Grimsby, West Yorkshire, UK
Novartis Pharmaceuticals' active pharmaceutical ingredients (API) plant complex in Grimsby, West Yorkshire, was first established in 1951.
Novavax and CPL Biologicals Influenza Vaccine Manufacturing Facility
Novavax, in association with CPL Biologicals, completed the construction of its new influenza vaccine manufacturing faci
Novavax Covid-19 Vaccine Manufacturing Facility
Novavax’s new vaccine manufacturing facility located in Bohumil, Czech Republic will develop and manufacture the company’s vaccine candidate for Covid-19, NVX‑CoV2373.
Novavax Vaccine Plant
Novavax is a biotechnology company developing a novel process to create vaccines against a wide range of infectious dise
Novo Nordisk decided in the spring of 2003 to market the long-acting insulin analogue Levemir (Insulin Detemir) first in
Novo Nordisk Insulin Cartridge, Chartres, France
Novo Nordisk is upgrading the insulin production plant at its facility in Chartres, Eure-et-Loir region, France. The Dan
Novo Nordisk Insulin Formulation and Filling Facility, Kaluga, Russia
In April 2015, Danish pharmaceutical company Novo Nordisk inaugurated an insulin formulation and filling facility at Grabtsevo Industrial Park in the Kaluga region of Russia.
Novo Nordisk Manufacturing Facility
Novo Nordisk's insulin manufacturing facility in North Carolina is located south-east of Raleigh near the town of Cla
Novo Nordisk Plant Expansion Tianjin
Novo Nordisk has had research and production facilities in China since 1994 when the company set up Novo Nordisk (Tianji
Novo Nordisk’s Type I Diabetes Research Facility, Seattle
The largest city in the north-western United States, Seattle, has become a hub for pharmaceutical research activity with the world's leading pharmaceutical companies establishing their research and development (R&D) centres there.
Novo Nordisk’s Diabetes Active Pharmaceutical Ingredients (DAPI) Production Facility, Clayton
Danish pharmaceutical company Novo Nordisk broke ground on its diabetes active pharmaceutical ingredients (DAPIs) production facility in Clayton, North Carolina, in March 2016.
Novoseven Facility, Hillerød
The NovoSeven pharmaceutical facility in Hillerød, Denmark was constructed by NNE (Novo Nordisk Engineering), the e
Novozymes Innovation Campus, Copenhagen
Denmark-based biotechnology company Novozymes is building an innovation campus in Copenhagen.
Nuclea Genomics Center
Nuclea Biotechnologies, a translational medicine and genomics firm, launched a new genomics centre, on 4 August 2010.
NuSil Technology’s Clean Room Manufacturing Facility
NuSil Technology opened a new clean room manufacturing facility on 14 April 2010. Located in Carpinteria, California, c
Organogenesis Cell Manufacturing Plant, Massachusetts
US-based regenerative medicine maker Organogenesis broke ground on the world's largest automated living cell manufacturi
Oxford Pharmaceuticals Generic Drug Facility, Birmingham, Alabama
In September 2015, US-based pharmaceutical start-up Oxford Pharmaceuticals broke ground on the construction of a generic drug manufacturing and distribution facility in Jefferson County, Birmingham, Alabama.
Parker Bioscience’s Manufacturing Facility Expansion, Birtley
Parker Bioscience Filtration, a subsidiary of US-based motion and control systems provider Parker Hannifin, has expanded the manufacturing capacity of its facility in Birtley, UK.
Parsolex’s CGMP Manufacturing Facility Expansion, West Lafayette, Indiana
Parsolex, a contract development and manufacturing organisation based in the US, partnered with Bosch Packaging Technology to equip its West Lafayette facility with the latest pharmaceutical packaging technologies, in November 2019.
Patheon Manufacturing Facility Expansion, Toronto
Canadian contract drug maker Patheon, completed the expansion of its Toronto manufacturing facility in April 2009, two m
Patheon Milton Park Facility
Patheon is one of the largest contract drug development and manufacturing service providers in the world. To meet the in
PBL’s Pharmaceutical Fermentation Facility, Wiltshire
In April 2018, Porton Biopharma Limited (PBL) opened a pharmaceutical fermentation facility at the Porton Down Science Park near Salisbury, Wiltshire, UK.
PCI’s Manufacturing Site Expansion, Bedford, New Hampshire, USA
PCI Pharma Services is building a 50,000ft² manufacturing facility at its Bedford campus to expand its portfolio.
PDL Bioharma Biotech Manufacturing
Protein Design Labs (renamed PDL Biopharma in 2005) announced plans to build a new manufacturing facility on a 29-acre s
Penang Biotech Park, Bukit Minyak, Malaysia
Penang Biotech Park is situated in the Bukit Minyak region of Malaysia in Penang (north-western coast of Peninsular Mala
Penn Pharmaceutical Tredegar Plant
Penn Pharmaceutical's Tredegar plant is located in the Tafarnaubach Industrial Estate in Gwent, South Wales, UK. Laun
Perkin Elmer Centre of Excellence, Singapore
According to a United Nation's report, Asia's population is expected to increase from 3.7 to 5.3 billion by 2050. With r
Pfizer Biologics Clinical Manufacturing Facility, Massachusetts
US-based pharmaceutical company Pfizer began building a biologics clinical manufacturing facility at its existing manufacturing facility in Andover, Massachusetts, in June 2016. The new facility will be used for producing high-quality, complex biologics and vaccines and is expected to come online by January 2019.
Pfizer Biotech Manufacturing Facility, Shanbally
In mid-2007 it was reported that Pfizer, one of the largest pharmaceutical companies present in the Republic of Ireland,
Pfizer European R&D Headquarters, Sandwich, Kent
Pfizer's Sandwich site is the company's European R&D headquarters and global manufacturing hub. Located in south-east Ke
Pfizer Genotropin Manufacturing, Strangnas
Pfizer is one of the largest pharmaceutical companies in the world. Recent restructuring has led to the company putting
Pfizer Global Biotechnology Centre, Hangzhou, China
US-based pharmaceutical company Pfizer broke ground for the development of a Global Biotechnology Centre in China's Hangzhou Economic Development Area (HEDA) in June 2016.
Pfizer New Manufacturing Facility, Dalian
On 27 February 2009 Pfizer opened a new manufacturing facility at its Dalian site in Liaoning Province, northeast China.
Pfizer R&D Facility
Pfizer's New London facility is a world-class research and development (R&D) centre located in the State of Connecticu
Pfizer R&D Facility, Chesterfield, Missouri
In June 2017, US-based biopharmaceutical company Pfizer began building a research and development (R&D) laboratory and office facility in Chesterfield, Missouri.
Pfizer’s Biotechnology Campus, Clondalkin, Ireland
Pfizer's Biotechnology Campus in Clondalkin, Ireland, was opened in September 2006.
Pfizer’s Bulk Pharmaceuticals Facility, Tuas, Singapore
The large-scale pharmaceutical facility in Tuas, Singapore, is Pfizer's first manufacturing facility in the country.
Pfizer’s Synthesis Facility, Ringaskiddy, Ireland
Pfizer will create additional manufacturing and laboratory spaces at its existing manufacturing sites in Ringaskiddy.
Pfizer, Newcon Containment Facility, Germany
Pfizer Manufacturing Deutschland GmbH is a large secondary manufacturing centre for Pfizer in Germany and has a reputati
Pfizer’s Gene Therapy Manufacturing Facility Expansion, North Carolina
Pfizer, a pharmaceutical company based in the US, is expanding its gene therapy manufacturing facility located at Sanford campus in North Carolina, US.
Pfizer’s Sterile Injectable Production Facility, Michigan
In June 2018, Pfizer announced plans to build a sterile injectables production facility at Portage in Kalamazoo County, Michigan.
Pharmacia Parenterals Plant, Uppsala, Sweden
Pharmacia's parenterals plant is located in Uppsala in Sweden and was originally ordered by a Swedish pharmaceuticals company called Pharmacia & Upjohn.
Pharmalucence New Production Facility
Massachusetts-based radiopharmaceutical product supplier, Pharmalucence, is constructing a new pharmaceutical manufactur
Pharmaniaga Small Volume Injectables (SVI) Facility
Pharmaniaga LifeScience's small volume injectables (SVI) facility in Puchong, in the Selangor district of Malaysia, commenced commercial production in January 2011.
Pharmatek Laboratories cGMP Facility
Pharmatek Laboratories operates a cGMP manufacturing facility in San Diego. The custom designed facility offers a rang
Pharmavite Vitamin and Supplement Manufacturing Facility, Alabama
Pharmavite officially opened a new dietary supplement manufacturing facility in the US in June 2013.
Pharmavite’s Vitamin and Supplement Manufacturing Facility, Ohio, USA
Pharmavite will build its fourth facility in New Albany, Ohio, to increase its dietary supplement manufacturing capacity by 2024.
Pharmstar Pharmaceuticals Plant, Rocky Mount, North Carolina
PharmStar Pharmaceuticals Inc is a relatively new drug manufacturer, which is headquartered in Rocky Mount, North Caroli
Phebra Manufacturing Facility, Sydney
Phebra officially opened a new pharmaceuticals manufacturing facility at Lane Cove West in Sydney, Australia, in March 2013.
Phillips-Medisize Pharmaceutical Manufacturing Facility, Wisconsin
Phillips-Medisize is constructing a pharmaceutical manufacturing facility in Hudson, Wisconsin, US.
Phillips-Medisize’s Manufacturing Facility Expansion, Struer
Phillips-Medisize is expanding its existing global innovation and development (GID) centre in Struer, Denmark.
Phoenix Biomedical Campus Innovation Centre, Arizona
The Phoenix Biomedical Campus (PBC) Innovation Centre is a new 225,000ft² research facility situated within the larger Phoenix Biomedical Campus in Phoenix, Arizona, US.
Phoenix Chemicals Manufacturing Facility
The Annan facility, situated on a 154-acre site in Dumfriesshire, is currently part of Phoenix Chemicals. It has three i
Piramal Pharma Solutions’ API Manufacturing Facility Expansion, Riverview, Michigan
Piramal Pharma Solutions (PPS) is expanding its manufacturing facility in Riverview, Michigan, with an investment of approximately $32m to develop and manufacture potent and non-potent active pharmaceutical ingredients (API).
Piramal Pharma Solutions’ Ahmedabad PDS Facility Expansion, India
Ahmedabad PDS facility expansion will enhance Piramal Pharma Solutions’ existing in-vitro biology capabilities.
Piramal Pharma Solutions’ Manufacturing Facility Expansion, Aurora, Canada
Piramal Pharma Solutions completed an expansion of its manufacturing facility in Aurora to produce APIs in May 2022.
Piramal’s ADC Manufacturing Facility Expansion, Grangemouth, Scotland
Piramal is expanding its manufacturing facility located in Grangemouth, Scotland, to increase its ADC production capabilities.
Plough Centre for Sterile Drug Delivery Systems, Memphis
Construction of a drug manufacturing facility for the University of Tennessee Health Science Centre in Memphis, Tennessee, is expected to begin in September 2015.
POINT Biopharma’s New Manufacturing Facility, Indiana
POINT Biopharma, a clinical-stage biopharmaceutical company, is planning to construct its first US manufacturing plant in Indianapoli, Indiana.
Polpharma Dry Forms II Production Facility, Starogard Gdanski, Poland
Polpharma began production at its Dry Forms II plant in Starogard Gdanski, Poland, in February 2001.
Prestige BioPharma’s Innovative Discovery Centre, Busan, South Korea
Prestige BioPharma will open the Innovative Discovery Centre, its first global-scale R&D centre, in Busan by 2023.
Prestige Biopharma’s Vaccine Production Centre, Osong, South Korea
Prestige BioPharma opened a global-scale vaccine manufacturing centre in Osong, South Korea, in December 2021.
Process Control Update at Cedarburg’s Intermediate and API Facility, Grafton, US
Cedarburg Pharmaceuticals awarded Emerson Process Management with a contract in 1998 to supply the company with process controls for its new facility in Grafton, Wisconsin, US.
Progenitor Cell Therapy (PCT) Manufacturing Facility, Allendale, New Jersey
Progenitor Cell Therapy (PCT) launched phase one of a new cell development and manufacturing facility on 26 January 2010
Prolor Biotech R&D Facility, Weizmann Science Park
Prolor Biotech, a clinical phase biopharmaceutical company formerly known as Modigene, has opened a new corporate headq
Promega Corporation’s Manufacturing Facility, Wisconsin
Promega Corporation began construction of a regulated product manufacturing facility at Feynman Centre in the city of Fitchburg, Wisconsin, US, in August 2011.
Promega’s Kornberg Research and Development Centre, Fitchburg, USA
In April 2021, US-based biotechnology company Promega opened the Kornberg Centre, a research and development (R&D) facility located in Fitchburg, Wisconsin.
Pronova Biopharma Pharmaceutical Production Facility
Pronova BioPharma is one of the leading companies in the research and development of marine-originated omega-3 fatty aci
Protchem Industries Derivatives Plant, Chennai, India
In 1999, construction began on a derivatives plant for Protchem Industries.
pSivida Biosilicon Manufacturing Plant
pSivida is an Australian nanotech company specialising in the commercialisation of biodegradable nanotech silicon device
PTC Therapeutics’ Gene Therapy Manufacturing Centre of Excellence, Hopewell, New Jersey
PTC Therapeutics’ biologics facility will be located within the Bristol-Myers Squibb (BMS) campus in Hopewell, New Jersey.
Public Health England’s (PHE) New Campus in Harlow, Essex
Public Health England (PHE) is developing a public health science campus and headquarters in Harlow, Essex, UK.
Quality Chemical Industries – HIV Drug Plant
HIV, AIDS and malaria are massive problems throughout Africa. The drugs to treat and prevent these diseases are readily
Quay Pharma Deeside Facility, Wales
Quay Pharma, a UK-based pharmaceutical outsourcing company, is relocating operations from its current facility in Brombo
Quintiles Drug Research Unit
Quintiles, a US-based biopharmaceutical services company, inaugurated its new research facility in London on 8 March 2
QuVa Pharma’s Pharmaceutical Manufacturing Facility Expansion, New Jersey
QuVa Pharma is expanding its biotech pharmaceutical manufacturing facility in Bloomsbury, New Jersey, US as part of its multi-year growth spree to extend its pharmaceutical facilities beyond Texas.
Regenxbio’s Research and Development Facility, Maryland
Regenxbio is building a research and development (R&D) facility in Montgomery County in Rockville, Maryland, US.
Regis Technologies’ API Development Laboratories Expansion, Morton Grove, Illinois
Regis Technologies, a US-based contract development and manufacturing organisation (CDMO), completed the expansion of its custom active pharmaceutical ingredients (APIs) development laboratory facilities in Morton Grove, Illinois, in February 2021.
Rentschler Biopharmaceutical Manufacturing Facility Expansion
Rentschler Biopharma is carrying out an expansion of its recently acquired biopharmaceutical manufacturing facility located in Milford, US. The project is part of the company’s plan to expand its business in the US and Europe.
Rentschler Biotechnologie, New Manufacturing Capacity
Rentschler Biotechnologie GmbH is a full-service contract manufacturer and part of the Rentschler Group based in Lauphei
Research Institute of the McGill University Health Centre (RI-MUHC), Montreal
The McGill University Health Centre (MUHC) and its Research Institute (RI-MUHC) inaugurated a jointly built research institute at MUHC's Glen site in Montreal, Canada, in February 2015.
Richter Gedeon Hormone Production Facility
Richter Gedeon Vegyeszeti Gyar Rt, a well-known Hungarian pharmaceutical company, opened a new hormone production facili
Richter-Helm BioLogics Plant
Richter-Helm owns a biologics plant at Hanover Medical Park, Germany. The plant has been operational since 1987. It was
Robert and Beverly Lewis Integrative Science Building, University of Oregon
University of Oregon’s (UO) new Robert and Beverly Lewis Integrative Science Building (LISB) was opened in November 2012.
Roche Biotechnology Plant, Basel
Roche's biotechnology plant in Basel opened in May 2007. The plant was developed on the existing Roche production site,
Roche Bulk Active Ingredient Manufacturing Facility, Florence, SC
Roche Carolina is the highly successful US subsidiary of pharmaceutical giant Hoffmann La Roche. Roche has operated a pr
Roche Diagnostics PCR Diagnostic Kits
Roche Diagnostics completed the construction and commissioning of a new manufacturing facility in Branchburg, New Jersey
Roche New Research and Development Facility
Roche's new R&D facility is located in Wettsteinallee near Basel, Switzerland. It was officially inaugurated in November 2011. Roche made an investment of $271m in the site.
Roche Pharmaceutical Manufacturing Plant
Roche Mustahzarlari has completed the construction of their pharmaceutical facility at Gebze, close to Istanbul, Turkey.
Roche Vitamin Plant, Taishan, Shanghai
Roche's latest vitamin plant is located in Taishan, Shanghai, which is in the northeastern part of the Peoples' Republic of China.
Roche Vitamins and Minerals Premix Plant, Republic of South Africa
Hoffman La Roche completed the first phase of construction for a vitamins and minerals premix plant at Isando, Republic of South Africa, in June 2002.
Roche’s Basel Site Expansion, Basel
Roche, the world's fourth biggest pharmaceutical company of 2014, announced its investment plans on a major infrastructure development project at its Basel site in Switzerland in October 2014.
Rocket Pharmaceuticals’ Research and Development (R&D) and Manufacturing Facility, Cranbury
Rocket Pharmaceuticals will build a new research and development (R&D) and manufacturing facility in Cranbury, New Jersey, US to support the production of its pipeline of lentivirus and adeno-associated virus (AAV) gene therapies.
Rohner Custom Synthesis Plant
In March 1999 Rohner AG began the construction of a new state-of-the-art pharmaceutical facility at its existing site at
Romark’s New Manufacturing Facility, Manati
Romark has built a new manufacturing facility in Manati, Puerto Rico, for the production of its diarrhoea drug, Alinia® (nitazoxanide), for the US market.
Rosalind Franklin Biotechnology Centre, Delft, Netherlands
Netherlands-based healthcare company Royal DSM has opened a new facility, the Rosalind Franklin Biotechnology Centre, at its campus in Delft.
Rosalind Franklin University’s (RFU) Innovation and Research Park, Chicago
Rosalind Franklin University (RFU) has announced plans for the construction of an innovation and research park at the university's North Chicago campus.
Roxane Laboratories Oral Solid Dosage Facility
Roxane Laboratories has upgraded its 500,000ft² west-side pharmaceutical manufacturing plant in Columbus, Ohio, to
Rubius Therapeutics’ Pharma Manufacturing Facility, Rhode Island, US
Rubius Therapeutics is constructing a pharmaceutical manufacturing facility in Smithfield, Rhode Island, US.
Rutgers University Chemistry and Chemical Biology Building, New Jersey
Construction of a new Chemistry and Chemical Biology (CCB) building began in June 2014 at the Rutgers University's Busch campus in New Jersey, US.
SAFC Dry Powder Media Manufacturing Plant, Irvine, Scotland
SAFC, a business unit of Sigma-Aldrich Corporation, opened a dry powder media (DPM) plant at its manufacturing facility in Irvine, Scotland, in January 2015.
SAFC Manufacturing Fermentation Facility
SAFC operates a contract manufacturing fermentation facility in Jerusalem, Israel. The facility is EU and FDA complian
SAFC Pharma API Manufacturing Expansion, Republic of Ireland
SAFC Pharma is a multinational operation, part of the US fine chemical company Sigma-Aldrich. SAFC specialises in provid
SAFC Pharma St Louis Facility, Missouri
SAFC Pharma's St Louis facility is a cGMP biologics manufacturing facility, which undertakes plant and animal-based ther
SAFC Verona HPAPI Manufacturing Facility
SAFC, a business division of Sigma-Aldrich, is a custom manufacturer and services provider for pharmaceutical and biopharmaceutical companies.
Sai Life Sciences’ New Research and Technology (R&T) Centre, Hyderabad
Contract development and manufacturing organisation (CDMO) Sai Life Sciences inaugurated its new research and technology (R&T) centre in Hyderabad, India in August 2020.
Sai Life Sciences’ Process Chemistry R&D Laboratory Expansion, Manchester
Sai Life Sciences announced the expansion of its process chemistry R&D laboratory at Alderley Park, Manchester, UK in January 2021.
SAJAPHCO JV’s Pharmaceuticals Formulation Plant, Saudi Arabia
In 1998, construction began on a new pharmaceuticals formulation plant in Jeddah, on the Red Sea coast of Saudi Arabia.
Salubrent Pharma Solutions Analytical Lab, Kannapolis, North Carolina
Salubrent’s analytical lab in Kannapolis, North Carolina, was built to help the company meet its long-term growth plans.
Samsung Biologics Bio Campus II, Incheon, South Korea
Samsung Biologics is building a second biopharmaceutical campus in the Songdo Industrial Cluster in Incheon, South Korea.
Samsung Biologics Manufacturing Plant, Incheon, South Korea
South Korea-based company Samsung Biologics broke ground on its first manufacturing plant in the free economic zone in Songdo, Incheon, in May 2011.
Samsung BioLogics’ Biological Manufacturing Facility, Songdo, South Korea
In October 2018, Samsung BioLogics opened its third biologics manufacturing plant in Songdo, South Korea. The plant made Samsung Group one of the world’s largest biologics contract manufacturing operators (CMOs).
Samsung Biologics’ P4 Super Plant, Songdo
Samsung Biologics is planning to expand its manufacturing facilities with the construction of its fourth biopharmaceutical manufacturing plant, P4-Super Plant, in Songdo, South Korea.
Sandoz Cefalosporin-Antibiotics Production Plant, Frankfurt, Germany
Biochemie (now Sandoz) has invested DM85 million ($41 million) in a new Frankfurt production plant which will become the
Sanford Consortium for Regenerative Medicine’s Stem Cell Research Facility
The Sanford Consortium for Regenerative Medicine (SCRM) inaugurated a new stem cell research facility in La Jolla in the state of California, US, in November 2011.
Sanofi Biologics Plant Expansion, Geel, Belgium
France-based pharmaceutical company Sanofi is expanding its biologics plant in Geel, Belgium, to add to its manufacturing and commercial production capabilities.
Sanofi Lantus SoloSTAR Pen Assembly Plant, Yizhuang, Beijing
Sanofi China opened a new assembling and packaging facility for prefilled insulin devices in Beijing, China, in May 2012. The facility will produce the SoloSTAR insulin injection pens.
Sanofi Manufacturing Plant, Goa, India
French pharmaceutical company Sanofi’s manufacturing facility in Goa, India, is located in the Verna Industrial Park, owned by Sanofi’s Indian arm Sanofi India, previously known as Aventis Pharma.
Sanofi Pasteur R&D Centre
Sanofi Pasteur, the vaccine division of Sanofi, opened a new vaccine research and development centre in Toronto, Ontar
Sanofi Pasteur Vaccine Plant, Val De Reuil, France
Sanofi Pasteur, the vaccines division of Sanofi Aventis, is focusing on a continuing technology upgrade and expansion. T
Sanofi Pasteur Vaccine Production Plant, Swiftwater, Pennsylvania
Sanofi Pasteur, the vaccines business of Sanofi-Aventis, is one of the largest seasonal influenza vaccine producers in t
Sanofi-Lonza Biologics Production Facility, Visp, Switzerland
Switzerland-based biopharmaceuticals supplier Lonza and French life sciences firm Sanofi have established a joint venture (JV) to set up a large-scale biologics production facility in Visp, Switzerland.
Sanofi’s Digital Manufacturing Facility, Massachusetts
Sanofi, a biopharmaceutical company based in France, opened a digital biopharmaceutical manufacturing facility in Framingham, Massachusetts, US, in October 2019.
Sanofi’s Evolutive Vaccine Facility (EVF), Neuville-sur-Saône
Sanofi is planning to build a new Evolutive vaccine facility (EVF) for the manufacturing of vaccines in Neuville-sur-Saône in the eastern part of France.
Sanofi’s Evolutive Vaccine Facility, Singapore
Sanofi will build its first-in-Asia, fully digitalised vaccine manufacturing facility in Singapore by 2025.
Sanofi’s Vaccine Manufacturing Facility, Toronto, Canada
French pharmaceutical company Sanofi Pasteur has unveiled plans to build a vaccine manufacturing facility in Toronto, Canada.
Sartorius Cell Culture Technology Centre, Germany
German biopharmaceutical and life sciences company Sartorius Stedim Cellca is developing a cell culture technology centre.
Sartorius’ Biopharmaceutical Manufacturing Facility Expansion, Puerto Rico
Sartorius has expanded its biopharmaceutical manufacturing facility Sartorius Stedim Campus, which is located in Yauco, Puerto Rico, US.
Saudi Vaccine and Biomanufacturing Centre
Saudi Vaccine and Biomanufacturing Centre is a research facility being constructed at the KAUST Research and Technology Park in Saudi Arabia for the development of vaccines and biopharmaceutical products.
SBL Vaccin Cholera Vaccine Production
In the second quarter of 2003 the Swedish vaccine producer, SBL Vaccin AB, brought on-line a major extension and upgrade
SCA Pharmaceuticals’ Manufacturing Facility, Windsor, Connecticut
In November 2017, US-based pharmaceutical company SCA Pharmaceuticals officially opened a manufacturing facility in Windsor, Connecticut.
Schering-Plough Production and R&D Facilities
Schering-Plough has continued to capitalise on its investment program into facilities based in Singapore. The company cu
SCHOTT Pharmaceutical Packaging Plant Expansion, Zavolzhe
SCHOTT opened the first GMP-compliant pharmaceutical packaging production facility in Russia in May 2011. The plant is located at Zavolzhe near Nizhny Novgorod city in Russia.
SCHOTT Pharmaceutical Plant Expansion
SCHOTT Pharmaceutical Packaging operates a cGMP manufacturing plant in Lebanon Valley Business Park, Pennsylvania, US.
Science Research and Innovation Facility, University of Windsor
In December 2018, the University of Windsor officially opened a new science research and innovation facility (SRIF) at its campus in Ontario, Canada.
Scientia Clinical Research Facility, University of New South Wales (UNSW)
Construction of the Scientia Clinical Research facility at the Randwick Hospitals campus of the University of New South Wales (UNSW) began in November 2014.
ScinoPharm Bulk Pharmaceutical Plant, Tainan County, Taiwan
The ScinoPharm bulk pharmaceutical plant is located at the Tainan Science Industrial Park in Shan Hua, Tainan County in southern Taiwan.
Scorpion Biological Services’ Large Molecule Biomanufacturing Facility in Manhattan, Kansas, US
Scorpion Biological Services’ new CDMO facility in Manhattan, Kansas, will focus on biodefence.
Scripps Prebys Cardiovascular Institute, California
The Scripps Prebys Cardiovascular Institute was opened for patient care in March 2015 after around four years of construction.
Seagen’s Biologics Manufacturing Facility, Everett, Washington
Seagen will build a facility in Everett, Washington, by 2024 to expand its cancer medicine manufacturing capabilities.
Searle Pharma Medication Production Plant, Moscow
In 2000 Searle Pharma (part of Pharmacia which combined/merged with Pfizer in April 2003) opened a $30m medication p
Seqens’ Boston R&D Centre, Devens, Massachusetts, USA
Seqens has opened a $5m facility to develop and manufacture drugs and therapeutics in Devens, Massachusetts.
Seqirus Vaccine Manufacturing Facility Expansion, North Carolina, US
Seqirus’ manufacturing facility expansion in Holly Springs aims to enhance its ability to respond to an influenza pandemic.
Seqirus’ Influenza Vaccine Manufacturing Facility, Melbourne
Seqirus, an influenza vaccine maker, is building a new cell-based influenza vaccine manufacturing facility in Melbourne, Australia.
Serologicals Corporation Biotech Production Plant
Serologicals Corporation finished the construction of a new biotechnology production facility in Lawrence, Kansas, US, i
Servier Paris-Saclay Research Institute, Paris
Servier Pharmaceuticals is constructing Servier Paris-Saclay research institute, a new research and development hub in the Paris-Saclay cluster, France, which is one of the world’s top eight invention clusters.
SGS Life Science Services Laboratory Facility, Mumbai, Maharashtra
In January 2012, SGS opened a new life sciences laboratory in Navi Mumbai, Maharashtra, India. It is SGS' second facility in India, the first being located in Chennai, Tamil Nadu.
Shanghai CP Guojan API Production Suite, Shanghai
Shanghai CP Guojian Pharmaceutical Co Ltd (CPGJ) is a biopharmaceutical company that was formed in January 1998. The com
Shanghai Roche Pharmaceuticals, Shanghai
Roche operates in China as Shanghai Roche Pharmaceutical Co Limited, which is a highly successful joint venture operated
ShangPharma Manufacturing and Pre-Clinical Research Facility, Shanghai
China-based pharmaceutical outsourcing partner ShangPharma has signed a deal with the Qidong Biopharma Industrial Zone in Qidong, China, to build a biologics manufacturing and pre-clinical research facility.
ShangPharma Pilot Plant Facility, Fengxian
China-based contract research organisation ShangPharma Corporation launched phase one of a new pharmaceutical developme
Sharp Packaging Solutions Facility Expansion, Pennsylvania
In June 2016, pharmaceutical packaging company Sharp Packaging Solutions officially opened its Centre of Excellence for speciality, biological and cold chain packaging in Allentown, Pennsylvania.
SHINE Medical Isotope Production Facility, Janesville, Wisconsin
US-based nuclear technology company SHINE Medical Technologies is building a medical isotope production facility in Janesville, Wisconsin.
SHINE Medical Isotope Production Facility, Veendam, Netherlands
US-based radiopharmaceutical company SHINE Medical Technologies is to build a medical isotope production facility in Veendam, Netherlands. The facility is intended to provide a reliable, flexible supply of a range of vital medical tracers and cancer treatment elements for customers in Europe.
Shionogi Pharmaceutical Research Facility, Osaka
Shionogi & Co's new pharmaceutical research facility is located in Toyonaka City in Osaka, Japan. The new facility was opened in August 2011. It is equipped with drug discovery research laboratories and laboratory equipment, as well as information technology capabilities.
SHL Medical Autoinjector Manufacturing Facility, South Carolina, USA
SHL Medical’s new facility in North Charleston, South Carolina, is expected to start operations by Q2 2024.
Shonan Research Center
Shonan Research Center is a new drug discovery and development centre located in Fujisawa City, Kanagawa prefecture, Japan.
Sidra Medical and Research Center, Doha
Located in Doha, Qatar, Sidra Medical and Research Center will be an ultramodern, all-digital academic medical centre, designed and planned to the highest international standards in technology, science and patient care.
Siegfried Holding Facility
Alliance Medical Products (AMP) operates a state-of-the art cGMP facility in Irvine, California, US.
Siemens Healthineers Facility Expansion, Walpole, Massachusetts
In June 2017, Germany-based medical technology company Siemens Healthineers began an expansion and refurbishment of its laboratory diagnostic manufacturing facility in Walpole, Massachusetts.
Sinergium Biotech Antigen Production Plant, Buenos Aires
Argentina-based biopharmaceutical company Sinergium Biotech has announced it will start building a primary antigen production plant in the town of Garin, located in Buenos Aires province.
SMC Group’s Pharmaceutical Development Services Facility, Cambridge, UK
SMC Group has opened a facility in Cambridge, UK, to offer pharmaceutical development services to customers.
Sofrigam Cold Chain Manufacturing Facility, Arras
Sofrigam opened its factory in Arras, France, in January 2008. The factory is used to test and manufacture temperature-controlled logistics packaging for the European market, and produces cold chain solutions for companies including GSK, Astra Zeneca and Pfizer.
Solagran Biotech Plant, Tomsk, Siberia, Russia
Solagran Ltd is a Melbourne, Australia-based biotechnology company. It has a portfolio of highly potent low side-effect,
Sorrel Medical’s New Manufacturing Facility, Netanya
Wearable drug delivery devices manufacturer Sorrel Medical opened a new manufacturing facility in Israel in July 2020.
South Australian Health and Medical Research Institute (SAHMRI), Adelaide
The South Australian Health and Medical Research Institute (SAHMRI) at North Terrace in Adelaide, South Australia, was officially opened in November 2013.
South Texas Research Facility
The University of Texas Health Science Center (UTHSC) opened the new South Texas Research Facility (STRF) at its campus in San Antonio, US, in October 2011.
Spaulding Clinical Research Facility
Spaulding Clinical Research completed a renovation of its clinical research facility on 20 August 2010. Located in Wes
STA Pharmaceutical’s Manufacturing Facility, Changzhou
STA Pharmaceutical (STA), a subsidiary of WuXi AppTec, opened its new large-scale oligonucleotide active pharmaceutical ingredient (API) manufacturing facility in Changzhou, China, in January 2020.
Stada Arzneimittel Supply Chain and Packaging Facility, Turda, Romania
Stada will build a supply-chain hub in Turda, Romania, with an investment of more than €50m ($51.9m).
STC Biologics’ GMP Manufacturing Facility, Massachusetts, US
In April 2019, STC Biologics opened a single-use mammalian good manufacturing practices (GMP) facility in Newton, Massachusetts, US.
Stelis’ Biologics Manufacturing Facility Expansion, Bangalore
Stelis BioSource™, a division of Stelis Biopharma, is expanding its biologics manufacturing facility located in Bangalore, India.
Stirling Pharma Pharmaceutical Production
Stirling Pharma's pharmaceutical plant in North Sydney, Nova Scotia, Canada, on a 300-acre business park was commissione